| Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone therapy – a double-blind randomized study- PROBES study (Progesterone Breast Endometrial Safety study) | Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone therapy – a double-blind randomized study- PROBES study (Progesterone Breast Endometrial Safety study) | EUCTR2021-001624-17-SE |
| Comparison of the effects of oral dydrogesterone and intramuscular progesterone on the construction of endometrial receptivity | Comparison of the effects of oral dydrogesterone and intramuscular progesterone on the construction of endometrial receptivity | ChiCTR2100042318 |
| Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer. | Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer. | NCT04722471 |
| Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles | Dydrogesterone Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) Cycles. | NCT04758871 |
| Oral versus vaginal progesterone for luteal phase support in frozen embryo transfer cycles. | Dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles. - REMODEL | EUCTR2020-004491-17-BE |
| Receptors marker in abnormal uterine bleeding | Correlation of endometrial estrogen and progesterone receptors along with blood vessels morphometry in different causes of abnormal uterine bleeding | CTRI/2021/01/030836 |
| Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies | Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies: a Randomised Controlled Trial | NCT04748562 |
| Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies | The Effectiveness of Cervical Pessary Versus Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies: a Randomized Controlled Trial. | NCT02623881 |
| Effect of Intramuscular Progesterone Supplementation on Clinical and Ongoing Pregnancy Rates in Patients With Low Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Frozen Cycles | Effect of Intramuscular Progesterone Supplementation on Clinical and Ongoing Pregnancy Rates in Patients With Low Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Frozen Cycles | NCT04837768 |
| Pharmacokinetics of Progesterone in Pregnancy-2 | Pharmacokinetics of Progesterone in Pregnancy-2 | NCT04753957 |
| Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle | Effects of E2 (Estradiol), P4 (Progesterone) and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle: Prospective Data Analysis | NCT04769401 |
| Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children | Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children | NCT04783857 |
| Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsia | Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsia | IRCT20210127050156N1 |
| Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates. | Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates | NCT04839627 |
| Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day | Effectiveness of Progesterone Supplementation for Women Having Low Progesterone Levels on the Day of Frozen Embryo Transfer | NCT04897269 |
| the Effect of Endometrial Compaction Caused by Progesterone Effect on Pregnancy Outcomes | The Effect of Progesterone Induced Endometrial Compaction on Pregnancy Outcomes in Frozen-thawed Embryo Transfer at the Blastocyst Stage | NCT04733235 |
| Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF) | Comparison of Crinone 8% Intravaginal Gel or Intramuscular Progesterone Supplementation for In Vitro Fertilization (IVF) and Embryo Transfer (ET) Cycles in Women Under Age 40 Years Old | NCT00656201 |
| MANAGEMENT OF FIRST TRIMESTER OF PREGNANCY WITH AYURVEDIC RASAYANA THERAPY AND MICRONIZED PROGESTERONE. | MANAGEMENT OF FIRST TRIMESTER PREGNANCY WITH RASAYANA THERAPY AND MICRONIZED PROGESTERONEâ?? A COMPARATIVE CONTROLLED CLINICAL TRIAL | CTRI/2020/12/030135 |
| Efficacy and safety of oral micronized progesterone that converts to allopregnanolone as an adjunctive treatment in refractory status epilepticus (Phase IIa study) | Efficacy and safety of oral micronized progesterone that converts to allopregnanolone as an adjunctive treatment in refractory status epilepticus (Phase IIa study) | TCTR20200717002 |
| Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters | Exploratory Study on the Impact of Different Doses and Route of Administration of Exogenous Progesterone in Artificial Endometrial Preparation Cycles on Endometrial Structure and Function | NCT04499131 |
| Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen | Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen | NCT04534881 |
| A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw Cycle | A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw Cycle | NCT04938011 |
| The influence of preovulatory and postovulatory progesterone on the outcome of the in vitro fertilization (IVF) | Efficacy of frozen/thawed embryo transfer and 5th day embryo transfer in the blastocyst stage on positive implantation and clinical pregnancy rate in female patients with low fertility linked to high preovulatory and postovulatory progesterone | ACTRN12615001315505 |
| Effect of rectal Progesterone on Latent Phase Prolongation in Patients with Preterm Premature Rupture of Membranes | Effect of rectal Progesterone on Latent Phase Prolongation in Patients with Preterm Premature Rupture of Membranes on Neonatal and Maternal outcomes , A clinical trial study | IRCT20200610047716N1 |
| Vaginal Progesterone for the Prevention of Preterm Birth in Women With History of Cervical Excision | Vaginal Progesterone for the Prevention of Preterm Birth in Women With History of Cervical Excision | ChiCTR2000037668 |
| Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer | A Phase II Trial of Preoperative Cisplatin and Bevacizumab in Estrogen Receptor (ER) Negative, Progesterone (PR) Negative, Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | NCT00580333 |
| Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. | A Multicenter, Randomized, Controlled, Double-blind, Double-dummy Study to Evaluate the Safety and Efficacy of Subcutaneous Progesterone Compared to Vaginal Progesterone for Luteal Phase Supplementation in Modified Natural Frozen Euploid Blastocyst Transfer. | NCT04549116 |
| Clinical efficacy and molecular mechanism of metformin combined with oral progesterone in the treatment of endometrial hyperplasia | Clinical efficacy and molecular mechanism of metformin combined with oral progesterone in the treatment of endometrial hyperplasia | ChiCTR2000038509 |
| The Effect of Progesterone Levels on Pregnancy | The Effect of Progesterone Levels on the 3rd and 5th Days After Insemination on Pregnancy | NCT04707430 |
| Child outcomes after prenatal progesterone for prevention of preterm birth, follow-up of the AMPHIA trial | Long-term follow-up of children exposed in-utero to progesterone for prevention of preterm birth: follow-up of the AMPHIA trial | NL-OMON27515 |
| Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion | Ability of Androgen-receptor Blockade to Normalize Progesterone-induced Augmentation of Gonadotropin Secretion in PCOS (CRM010) | NCT04597099 |
| Pharmacokinetics of allopregnanolone after multiple dose administration of progesterone in post-menopausal healthy volunteer women. | Pharmacokinetics of allopregnanolone after multiple dose administration of progesterone in post-menopausal healthy volunteer women. | ACTRN12620001102965 |
| Progesterone for transgender women | Effect of micronised progesterone on sleep in transfeminine individuals: a prospective case-control study | ACTRN12620001130954 |
| Comparing two routes of administration of progesterone hormone for support in fertilization via intrauterine insemination | Comparison of oral dydrogesterone with vaginal progesterone for luteal phase support in intrauterine insemination | ISRCTN38513865 |
| Study of the effect of an additional administration of Amelgen® 400 mg in women with a low progesterone value on the day of embryo replacement | Randomized controlled trial comparing micronized progesterone (Amelgen ®) 400 mg BID versus 400 mg TID for luteal support in artificial vitrified/warmed single blastocyst transfer cycles with low progesterone on day of embryo transfer - PROTECTA | EUCTR2020-004112-10-BE |
| Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial | Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial - ProFET | EUCTR2020-005552-38-SE |
| Progesterone for Breast Development in Trans Women | Progesterone for Breast Development in Trans Women; Assessment of effects and safety -a pilot trial- | NL-OMON21386 |
| Evaluation of pregnancy outcomes in IVF cycles with uterine support with progesterone, Prolotex, and Cyclogest in the infertility center. | Evaluation of pregnancy results in IVF cycles with luteal phase support with progesterone, prolotex, and Cyclogest in infertility center. | IRCT20141217020351N12 |
| Progesterone for Breast Development in Trans Women; Assessment of effects and safety -a pilot trial- | Progesterone for Breast Development in Trans Women; Assessment of effects and safety -a pilot trial- - Progesterone in Trans Women | NL-OMON49293 |
| Micronised progesterone for sleep in transgender women | Short-term effects of micronised progesterone on sleep quality in transfeminine individuals: arandomised, placebo-controlled cross-over trial | ACTRN12620001364965 |
| A clinical trial to study the effects of two drugsDydrogesterone and micronized progesterone in pregnant women with threatened abortion | Comparison of oral Dydrogesterone and oral Micronized progesterone in reducing the risk of miscarriage in pregnant women with threatened abortion. | CTRI/2020/10/028244 |
| Hysteroscopic Findings in Women Using Progesterone Only Pills (Minipills) | Hysteroscopic Findings in Women Using Progesterone Only Pills (Minipills) Prospective Cohort Study . | NCT05024604 |
| Bioequivalence study of vaginal progesterone suppository 400 mg | Bioequivalence study of vaginal progesterone suppository 400 mg of Ati Farmed pharmaceutical company compared to progesterone 400 sample manufactured by L.D. Collins&Co.,Ltd. England on healthy volunteers | IRCT20230222057495N4 |
| Progesterone Action on Endometrium of PCOS | Abnormalities of the Endometrium Persist Despite Adequate Progesterone Supplementation in the Polycystic Ovary Syndrome | NCT05062135 |
| 6 dosage vs 7 dosage of progesterone for slow growing embryo | The ideal duration of Progesterone exposure during HR-FET before transferring slow-growing D-6 frozen embryo | CTRI/2023/02/049543 |
| Investigating the effect of increasing the amount of prescribed progesterone on the pregnancy success rate | Investigating the effect of daily intramuscular injection of 50 mg progesterone and 800 mg progesterone suppository on the pregnancy success rate in women with low progesterone levels | IRCT20150105020558N6 |
| Comparison of two methods of estrogen and progesterone hormone administration and endometrial preparation in normal ovarian cycle in endometrial preparation for embryo transfer. | Comparison of freeze embryo transfer cycle results in modified natural cycle versus hormone replacement therapy | IRCT20130603013566N11 |
| Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient | A Randomized Controlled Study of Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patients in Intracytoplasmic Sperm Injection Cycles | NCT05847660 |
| MIcronized PROgesterone in Frozen Embryo Transfer Cycles | A Phase III Randomized Controlled Trial Comparing the Efficacy, Safety and Tolerability of Two Formulations of Vaginal Micronized Progesterone | NCT05899010 |
| Efficacy of Micronized Natural Progesterone Vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. | Evaluation of the Efficacy of Micronized Natural Progesterone (Seidigestan®) Vs GnRH Antagonist (Astarté®) in the Prevention of LH Peak During Controlled Ovarian Stimulation: a Randomized Clinical Trial. | NCT05954962 |
| Ovulation induction and luteal phase support with GnRH agonists in in vitro fertilization | SOLOAGO - Luteal phase support by GnRH agonist alone after GnRH agonist triggering compared to the reference protocol (hCG triggering and luteal support with progesterone) in IVF: a randomized controlled trial. - APHP220667 | CTIS2023-505126-34-00 |
| Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration. | Optimal Timing of Euploid Day 6 Blastocyst (blastocyst Which Was Biopsied on Day 6 After Fertilization) Transfer in Frozen Hormonal Replacement Therapy Cycles: Day 6 or Day 7 of Progesterone Administration? | NCT05980091 |
| Assessment of Two Methods for Progesterone Dosage During IVF | Comparison of Two Methods to Assess Progesterone Concentration in Patient During IVF Protocol on Triggering Day: Salivary Versus Blood Test | NCT05987657 |
| Adjunctive Vaginal Progesterone in Management of Preterm Labor | Adjunctive Vaginal Progesterone (Micronized Progesterone Effervescent Vaginal Tablet) in Management of Preterm Labor: A Randomized Controlled Trial | NCT05997563 |
| Vaginal Progesterone Improves Clinical Outcomes of RIF Patients | A Single-center Randomized Controlled Trial of Vaginal Progesterone to Improve Clinical Pregnancy Outcomes in Patients With Repeated Implantation Failure | NCT06005207 |
| Different routes of progesterone administration for sustaining implantation in in vitro fertilisation patients: impact on pregnancy and live birth rates | Oral dydrogesterone associated with vaginal micronized progesterone supplementation vs vaginal micronized progesterone alone supplementation for luteal phase support in in vitro fertilization patients: effects on pregnancy and live birth rates | ISRCTN52148405 |
| Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles | Luteal Phase Support With GnRH Agonist Alone After GnRH Agonist Triggering and Fresh Embryo Transfer Compared to the Reference Protocol (hCG Triggering and Progesterone Luteal Support): a Randomised Controlled Trial | NCT06150703 |
| Comparison of two different vaginal preparations of progesterone for prevention of recurrent preterm birth: A Randomized Controlled Trial | Comparison of two vaginal preparations of micronized progesterone for prevention of recurrent preterm birth (effervescent vaginal tablet and gelatin capsule): A Randomized Controlled Trial | CTRI/2023/01/048696 |
| Efficacy of Vaginal Progesterone for Maintenance Therapy in Arrested Preterm Labor: A Randomized Controlled Trial | Efficacy of vaginal progesterone for maintenance therapy in arrested preterm labor: A Randomized Controlled Trial | TCTR20230901006 |
| Effect of Progesterone on pregnancy prolongation among women with Placenta Previa - A Randomized Controlled trial | Effect of Progesterone on pregnancy prolongation among women with Placenta Previa - A Randomized Controlled trial - nil | CTRI/2023/10/058751 |
| The effect of oral dydrogesterone in supporting the luteal phase in patients undergoing in vitro fertilization treatment | Comparison of the effect of oral dydrogesterone with intramuscular progesterone in supporting the luteal phase in patients undergoing in vitro fertilization treatment, a non-inferiority clinical trial | IRCT20200421047152N5 |
| In vitro study of the effects of sugammadex on the measurement of serum concentrations of progesterone in premenopausal women – an assay validation study | In vitro study of the effects of sugammadex on the measurement of serum concentrations of progesterone in premenopausal women – an assay validation study | ACTRN12624000036516 |
| Evaluation of progesterone suppository in reducing preterm labor in high uterocervical angle | Evaluation of the effect of progesterone suppository on reducing the rate of preterm labor in patients with utererocervical angle above 105 ° | IRCT20190208042655N3 |
| Clinical efficacy of acupoint catenary embedding combined with progesterone in the treatment of obese endometrial atypical hyperplasia | Clinical efficacy of acupoint catenary embedding combined with progesterone in the treatment of obese endometrial atypical hyperplasia | ChiCTR2400080879 |
| Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments | Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Women Undergoing Assisted Reproductive Treatments | NCT06297564 |
| comparison of effect between Oral Dydrogesterone and Oral Micronized Progesterone in treating Threatened Miscarriage | An Open-Label, Randomized Controlled Trial to Compare the Efficacy and Safety of Oral Dydrogesterone Versus Oral Micronized Progesterone in Treating Threatened Miscarriage and in Modulation of Immune Factors - NIL | CTRI/2024/02/063174 |
| Comparison of Progesterone based stimulation with conventional protocol during the luteal phase of menstrual cycle in poor ovarian responders undergoing dual stimulation (DuoStim) | Progesterone-primed versus conventional antagonist stimulation during the luteal phase in poor ovarian responders undergoing Duo-Stimprotocol- a pilot study - NIL | CTRI/2024/03/064504 |
| The role of progesterone in ovulation | The role of progesterone as an ovulation trigger in IVF and IUI cycles, a clinical trial | IRCT20240506061667N1 |
| Cerclage with Progesterone Versus Progesterone Only in Singleton Pregnancies | Cervical Cerclage with Vaginal Progesterone Versus Vaginal Progesterone Only for Preterm Birth Prevention in Women with a Singleton Pregnancy and a Short Cervical Length: a Randomized Clinical Trial | NCT06463652 |
| Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial. | Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial - ProFET | CTIS2024-512844-40-00 |
| Effect of ovulatory progesterone elevation on natural cycle freeze-thaw embryo outcomes: a retrospective cohort study | Effect of ovulatory progesterone elevation on natural cycle freeze-thaw embryo outcomes: a retrospective cohort study | ChiCTR2400085557 |
| Progesterone in luteal phase support in patients undergoing embryo transfer cycle | A Comparison of Oral Dydrogesterone with Vaginal and Intramuscular Progesterone for Luteal Phase Support in In vitro Fertilization | IRCT20240421061550N1 |
| Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation | Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation | NCT06100783 |
| Evaluation of serum progesterone level on the day of embryo transfer in frozen cycle at cleavage stage on pregnancy outcomes in two routes of luteal phase support in infertile women refereed to Infertility center affiliated to Hormozgan University of Medical Sciences : A randomized clinical trial study | Evaluation of serum progesterone level on the day of embryo transfer in frozen cycle at cleavage stage on pregnancy outcomes in two routes of luteal phase support in infertile women refereed to Infertility center affiliated to Hormozgan University of Medical Sciences : A randomized clinical trial study | IRCT20200905048630N2 |
| Development and promotion of non-progesterone fertility preservation therapy for young endometrial carcinoma | Development and promotion of non-progesterone fertility preservation therapy for young endometrial carcinoma | ChiCTR2200067099 |
| Does progesterone luteal phase support increase live birth rates in couples undergoing intra-uterine insemination with Mild Ovarian HyperStimulation (MOH/IUI treatment), and is this addition to the treatment cost-effective? (The LUMO study) | Luteal Phase Support in MOH-IUI treatment (LUMO study) - V0001227 | CTIS2022-501534-33-00 |
| Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome | Phase II 6-month cyclic progesterone/spironolactone pilot therapy trial in polycystic ovary syndrome: pre-post, single-arm feasibility study | ISRCTN99343883 |
| EVALUATION OF THE EFFECT OF ADDING GNRH AGONIST TO THE DUAL PROGESTERONE (INTRAMUSCULAR AND VAGINAL) AS LUTEAL PHASE SUPPORT IN FROZEN-THAWED EMBRYO TRANSFERS DURING ARTIFICIAL CYCLES: A RANDOMIZED CONTROLLED TRIAL. | Evaluation of the effect of Adding Single-dose Gonadotrophins Releasing Hormone Agonist for Luteal Phase Support in frozen embryo transfer in antagonist IVF/ICSI cycles. | CTRI/2021/09/036421 |
| Natural Progesterone for the Treatment of Recurrent Glioblastoma | Pilot Study of Subcutaneously Administered Natural Progesterone for the Treatment of Recurrent GBM | NCT05091866 |
| Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route | Randomized, Two-sequence, Two-treatment, Four-period, Open Label, Single Dose, Crossover, Intravaginal Bioequivalence Study of 200 mg Soft Capsule Progesterone vs Utrogestan® in Healthy Female Subjects Under Fasting Conditions. | NCT05125627 |
| Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects | Randomized, Two-Sequence, Two-Treatment, Four-Period, Open-Label, Single Oral Dose, Crossover Bioequivalence Study of Progesterone 200 mg Soft Capsule vs Utrogestan® in Healthy Female Subjects Under Fasting Conditions | NCT05125640 |
| Comparison of the effect of oral progesterone and vaginal progesterone on luteal phase support | Comparison of the effect of oral progesterone and vaginal progesterone on luteal phase support using available drugs in IVF/ICSI candidates | IRCT20211101052938N1 |
| frozen cycles following endometrial preparation with estrogen and progesterone compared with tamoxifen | Evaluation of pregnancy outcomes in frozen cycles following endometrial preparation with estrogen and progesterone compared with tamoxifen in women with Polycystic Ovary Syndrome | IRCT20110509006420N23 |
| The effect of serum progesterone on third day after intrauterine insemination (IUI) on pregnancy outcomes in two different methods of progesterone administration | Evaluation of serum progesterone level on third day after intrauterine insemination on pregnancy outcomes in two routes of luteal phase support in women with unexplained infertility : A randomized clinical trial study. | IRCT20200905048630N3 |
| Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study. | Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study. | NCT05161338 |
| Modelling of allopregnanolone concentrations after multiple dose administration of progesterone. | Pharmacokinetics of allopregnenolone after multiple dose administration of progesterone: confirmation of modelled data. | ACTRN12621001763831 |
| Effect of progesterone and aspirin on refusing uterine artery resistance and pregnancy outcome | Comparison of progesterone and two different doses of aspirin effect on refusing uterine artery resistance and pregnancy outcome | IRCT20160308026962N5 |
| Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles | A Prospective Randomized Study of the Impact of Hormonal Monitoring and Progesterone Supplementation Adjustment on Outcome of Programmed Thawed Embryo Transfer Cycles | NCT05189145 |
| Sexual Intercourse and Vaginal Absorption of Progesterone | Sexual Intercourse and Vaginal Absorption of Progesterone : Cross-over Prospective Study | NCT05232344 |
| Effects of Fuke Zaizao Pill(Capsule) combined with progesterone in the treatment of polycystic ovary syndrome: a study protocol for a multi-center, randomized controlled clinical trial | Effects of Fuke Zaizao Pill(Capsule) combined with progesterone in the treatment of polycystic ovary syndrome: a study protocol for a multi-center, randomized controlled clinical trial | ChiCTR2200066957 |
| Comparison of the efficacy of oral Dydrogesterone with Micronized vaginal Progesterone for luteal phase support in women undergoing In vitro fertilization at the Federal Medical Centre Abuja: a randomized clinical trial | Comparison of the efficacy of oral Dydrogesterone with Micronized vaginal progesterone for luteal phase support in women undergoing In vitro fertilization (IVF) at the Federal Medical Centre Abuja: a randomized clinical trial | PACTR202202641392530 |
| Evaluation of 2% progesterone cream efficacy in the treatment of patients with bed sores | Evaluation of 2% progesterone cream efficacy in the treatment of patients with bed sores: a double-blind randomized clinical trial | IRCT20190810044500N24 |
| Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support | Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support in Intrauterine Insemination | NCT05276531 |
| HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss | hCG or Progesterone Effect on Unexplained Recurrent Pregnancy Loss | NCT05365464 |
| Effects of Vaginal Progesterone on Prevention of Preterm Delivery in Pregnant Women with Prior Spontaneous Preterm Birth | Effects of Vaginal Progesterone on Prevention of Preterm Delivery in Pregnant Women with Prior Spontaneous Preterm Birth | TCTR20220527007 |
| The Application Value of New Serum Markers CNN2 Combined with hCG and Progesterone in the Early Diagnosis of Ectopic Pregnancy: A Multi-center, Prospective Clinical Study | The Application Value of New Serum Markers CNN2 Combined with hCG and Progesterone in the Early Diagnosis of Ectopic Pregnancy: A Multi-center, Prospective Clinical Study | ChiCTR2200061747 |
| The Importance of Embryo Transfer Day Progesterone Value in Natural Cycle Frozen Embryo Transfers and the Evaluation of the Effect of Rescue Therapy on Pregnancy Outcomes in Patients With Low Progesterone Levels | The Importance of Embryo Transfer Day Progesterone Value in Natural Cycle Frozen Embryo Transfers and the Evaluation of the Effect of Rescue Therapy on Pregnancy Outcomes in Patients With Low Progesterone Levels: A Multicentric Randomized Controlled Study. | NCT05481684 |
| Evaluation and comparison of luteal phase support with vaginal and oral progesterone in IUI in Kernan in 2022 | Evaluation and comparison of luteal phase support with vaginal and oral progesterone in IUI | IRCT20151004024335N5 |
| Frozen-warmed embryo transfer after 6 or 7 days of progesterone administration for day 6 blastocysts in hormone replacement therapy cycles: a randomized controlled trial | Frozen-warmed embryo transfer after 6 or 7 days of progesterone administration for day 6 blastocysts in hormone replacement therapy cycles: a randomized controlled trial | ChiCTR2200062901 |
| Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia | Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia | IRCT20151228025732N72 |
| Comparison of endometrial receptivity inpatients used progesterone vaginal sustained-release gel 8% and intramuscular progesterone injection | Comparison of endometrial receptivity inpatients used progesterone vaginal sustained-release gel 8% and intramuscular progesterone injection | ChiCTR2200063485 |
| Rescue Progesterone Supplementation During Frozen Embryo Transfer | Rescue Progesterone Supplementation in Patients With Low Progesterone on the Day of Embryo Transfer for Artificial Endometrial Preparation Cycles: a Non-inferiority Study | NCT05555121 |
| Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy | Safety of Oral Micronized Progesterone Versus Norethisterone Acetate in Continuous Combination With Oral Estrogen as Menopausal Hormone Therapy - a Double-blind Randomized Study- PROBES Study (Progesterone Breast Endometrial Safety Study) | NCT05586724 |
| Efectiveness of dydrogesterone and progesterone in prevention of preterm birth in women with a short cervix | Effectiveness of Dydrogesterone and Progesterone in prevention of preterm birth in women with a short cervix | IRCT20221107056426N1 |
| Does adding progesterone to dexamethasone in patients with brain swelling caused by cancer allow the use of lower doses of dexamethasone in the future? | PROgesterone as a Steroid SParing agent against oEdema occurring with secondary bRain cancers (PROSSPER) | ISRCTN16167828 |
| The pharmacokinetic study of progesterone and allopregnanolone in refractory epilepsy : Phase II study | Prospective, open-label study of progesterone to manage seizure in Drug resistant epilepsy | TCTR20200710005 |
| Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes. | Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes | NCT03740568 |
| Progesterone after mifepristone, for women whose decision has changed after commencing a medical termination of pregnancy - a pilot clinical trial | Progesterone after mifepristone – pilot for efficacy and reproducibility (PAMper Trial): a prospective single-arm clinical trial of progesterone after mifepristone for women whose decision has changed regarding medical termination of their pregnancy. | ACTRN12620000596909 |
| Progesterone Augmentation of Nicotine Replacement Therapy Study | Progesterone Augmentation of Nicotine Replacement Therapy Study | NCT02685072 |
| Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants with Previously Untreated Locally Advanced, Inoperable (cannot be removed surgically), or Metastatic (spread to other locations in the body) Triple Negative Breast Cancer (breast cancer that does not have receptors for Oestrogen and progesterone hormones or HER2 proteins). | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1. | EUCTR2021-005743-79-ES |
| Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle | Comparison Between Agonist Trigger With HCG Luteal Phase Supplementation vs HCG Trigger With Progesterone Luteal Phase Supplementation in Antagonist Controlled HyperstimulationCycle Regarding Clinical Pregnancy Rate | NCT04846218 |
| Effect of Timing Progesterone Luteal Support on Embryo Transfer | Does the Time of Starting Progesterone (P4) Luteal Support (LS) Affects Embryo Transfer (ET) in Long Agonist Protocol Down-regulated ICSI Cycles? | NCT03040830 |
| Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow | Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow: A Randomized, Double-masked, Placebo-controlled Trial | NCT02779582 |
| The effect of increasing levels of the progesterone hormone on pregnancy rate | Comparison of fresh and frozen cycles of pregnancy in patients with increased progesterone level on the day of HCG injection | IRCT2016122131508N1 |
| Progesterone and Cervical Pessary in Twins | Progesterone and Cervical Pessary in Twins : A Prospective and Randomized Study to Prevent Preterm Birth (PRECEPT) | NCT03058536 |
| Hyperandrogenemia and Altered Day-night LH Pulse Patterns | Study to Evaluate if Androgen-receptor Blockade (Spironolactone) Improves Progesterone-suppression of Wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism | NCT03068910 |
| EARLY PREGNANCY CARE | Management of First trimester Pregnancy with Rasayana and Nasya and Micronized progesterone A Randomized controlled clinical trial | CTRI/2017/02/007969 |
| Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants with Previously Untreated Locally Advanced, Inoperable (cannot be removed surgically), or Metastatic (spread to other locations in the body) Triple Negative Breast Cancer (breast cancer that does not have receptors for Oestrogen and progesterone hormones or HER2 proteins). | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1. | EUCTR2021-005743-79-FR |
| Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome | Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome | NCT03088046 |
| Double-blind trial investigating the efficacy of different doses of Progesterone compared with placebo for treatment of hot flashes | Double-blind trial investigating the efficacy of different doses of Progesterone compared with Placebo for treatment of vasomotor symptoms - Treatment of vasomotor symptoms with oral Progesterone | EUCTR2016-004386-12-DE |
| Phase III trial on hormonal therapy versus standard chemotherapy for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. | Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial - LEPRE Trial | EUCTR2020-003066-39-IT |
| Comparison of the efficacy of Spironolcatone 5% and Progesterone 2% on hair density and diameter in female pattern hair loss | Comparison of the efficacy of Spironolcatone 5% and Progesterone 2% on hair density and diameter in female pattern androgenetic alopecia | IRCT201512252581N4 |
| Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles | Subcutaneous Versus Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles: Which is the Preference Expressed by the Patients? | NCT03181685 |
| The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage | The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage | ChiCTR-IOR-17011593 |
| Study of Progesterone in Treatment of Vasomotor Symptoms | Double-Blind Trial Investigating the Efficacy of Different Doses of Progesterone Compared With Placebo for Treatment of Vasomotor Symptoms | NCT03202186 |
| Vaginal Progesterone Supplementation in the Management of Preterm Labor | Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized, Double Blind, Controlled Trial | NCT03202836 |
| Pregnancy outcomes when adding a progesterone pessary dose amongst women who are receiving frozen embryo transfer with hormone replacement therapy, compared with placebo. | Prospective randomised trial of change of progesterone dosage in HRT FETs with low serum progesterone concentrations after 2 days of progesterone pessary treatment | ACTRN12617001016325 |
| A window of opportunity study to assess the biological effects of progesterone in premenopausal ER-positive, PgR-positive early breast cancer | A window of opportunity study to assess the biological effects of progesterone in premenopausal ER-positive, PgR-positive early breast cancer - PEARL | EUCTR2017-001521-41-GB |
| Serum Progesterone on the Day of Embryo Transfer and Pregnancy Rate. | Impact of Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Endometrial Preparation Cycles on the Ongoing Pregnancy Rate. | NCT03272412 |
| Endometrial Polyps Regression With Progesterone Therapy | Efficacy of Subcutaneous Progesterone in Premenopausal Woman With Endometrial Polyp: a Multicentric Randomized Control Trial | NCT03309709 |
| Benefit of giving estrogen in IVF cycles. | To determine the efficacy of estradiol along with progesterone as luteal phase support support in women undergoing In -Vitro fertilization. | CTRI/2017/10/010083 |
| Pharmacokinetics of Progesterone in Pregnancy | Pharmacokinetics of Vaginal Progesterone in Pregnancy | NCT03340701 |
| Oral Versus Parental Progesterone in the Management of Preterm Labor | Oral Versus Parental Progesterone in the Management of Preterm Labor | NCT03343795 |
| Progesterone Variation on the Final Day of Oocyte Maturation. | Progesterone Variation on the Final Day of Oocyte Maturation. A Prospective Cohort Study With Repeated Measurements | NCT03366025 |
| To evaluate the role of Hydroxy-progesterone in prevention of chemotherapy induced neurotoxicity in women with breast cancer | A Randomized controlled study to evaluate the role of Hydroxy-progesterone in prevention of chemotherapy induced neurotoxicity in women with breast cancer - Hydroxy Progesterone in reduction of chemotherapy induced neurotoxicity in breast cancer | CTRI/2015/11/006381 |
| Chinese Herbal Medicine and/or Oral Progesterone Intervention Trial for Threatened Miscarriage | Chinese Herbal Medicine and/or Oral Progesterone for Live Births in Threatened Miscarriage: An International Cooperative Multicenter Randomized Controlled Trial (CHOP-IT) | NCT02633878 |
| Progesterone and Doppler in Recurrent Abortion | Role of Serum Progesterone and Doppler Ultrasound in Prediction of Pregnancy Outcome in Women With Recurrent Unexplained Abortion | NCT03267771 |
| Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer | Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer | NCT03395665 |
| Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor | Comparison of the Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor | NCT02989519 |
| Pharmacokinetic properties of vaginal progesterone gel in Chinese healthy postmenopausal women | Pharmacokinetic properties of vaginal progesterone gel in Chinese healthy postmenopausal women | ChiCTR-IIR-16009879 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | Impact of Serum Progesterone Levels on the Day of Embryo Transfer on the Success Rate in Egg Donation Cycles Under Hormonal Replacement | NCT02696694 |
| Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases | Immunomodulatory Effects of Subcutaneous Progesterone in Patients Undergoing IVF Affected by Autoimmune Diseases | NCT04665232 |
| Vaginal Progesterone in Twin With Short Cervix | Evaluation of the Role of Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation With Short Cervix: Randomised Controlled Trial | NCT02697331 |
| Comparison of postoperative administration between dienogest and ultra low dose estrogen and progesterone tablet for suppressing recurrence of ovarian endometriomas: A randomized study | Comparison of postoperative administration between dienogest and ultra low dose estrogen and progesterone tablet for suppressing recurrence of ovarian endometriomas: A randomized study - Comparison of postoperative administration between dienogest and ultra low dose estrogen and progesterone tablet for suppressing recurrence of ovarian endometriomas: A randomized study | JPRN-UMIN000020865 |
| Prevention of preterm birth | Three-arm randomised trial of cervical cerclage, arabin pessary and vaginal progesterone to prevent spontaneous preterm birth in asymptomatic women at high-risk of preterm birth: A feasibility study | ISRCTN11186205 |
| Vaginal progesterone plus cervical pessary for preventing preterm birth | The effectiveness of the combined treatment with vaginal progesterone plus cervical pessary compared to vaginal progesterone monotherapy for the prevention of preterm birth: a randomized clinical trial. | IRCT201603109568N15 |
| The effect of progesterone in patients with premature rupture of membranes | The effect of progesterone in patients with premature rupture of membranes | IRCT201512077676N4 |
| Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles | Comparison of Vaginal Progesterone Gel (Crinone 8%®) and Intramuscular Progesterone in Vitrified-Warmed Blastocyst Transfer Cycles | NCT02772120 |
| Comparison of Day 19 and Day 20 Artificial FET | Assessment of Artificial FET Reproductive Outcomes: Transfer of Blastocysts on Progesterone + 4 Versus Progesterone + 5 | NCT02788097 |
| Comparative study between Nifedipine, Progesterone and Ritodrine for maintenance tocolysis in management of preterm labour | Comparative study between Nifedipine, Progesterone and Ritodrine for maintenance tocolysis in management of preterm labour prospective randomized trial | ACTRN12616000748415 |
| Progesterone in Patients With Placenta Previa | Efficacy of Prophylactic Vaginal Progesterone in Prevention of Preterm Delivery in Women With Placenta Previa | NCT03633175 |
| The effect of dydrogesterone and various forms of progesterone in support of artificial reproduction techniques | Comparison of oral dydrogesterone versus other forms of progesterone as a luteal cycles support in assisted reproductive technology (ART) | IRCT2016010825902N1 |
| Progesterone and Aminophylline for the Prevention of Preterm Labour | A Randomised Controlled Feasibility Study of the Tolerability of the Combination of Progesterone and Aminophylline for the Prevention of Preterm Labour | NCT03152942 |
| Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth | A Pilot Study of Vaginal Progesterone to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy | NCT02970552 |
| Efficacy Study of Progesterone Tablet in Post-menopausal Women | Effect of Progesterone 5, 10, and 20 mg Tablets Compared To Progesterone 100 mg Capsules on the Endometrial Thickness of Post-Menopausal Women Under Hormone Therapy - A Prospective, Open-Label, Randomized, Four-Arm, Parallel-Group, Phase II Clinical Trial | NCT02841137 |
| Trial of prevention of preterm birth in pregnancy after abdominal trachelectomy by vaginal progesterone | Trial of prevention of preterm birth in pregnancy after abdominal trachelectomy by vaginal progesterone - Trial of prevention of preterm birth in pregnancy after abdominal trachelectomy by vaginal progesterone | JPRN-UMIN000023161 |
| Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone | Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone - Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone | JPRN-UMIN000023080 |
| Pessary (cervical Ring) plus Progesterone to prevent Preterm delivery | Pessary plus Progesterone to prevent Preterm delivery in women with short cervical length: randomized clinical trial | RBR-3t8prz |
| Role of inflammatory markers in recurrent pregnancy loss and effect of oral micronized therapy on these cases | To study the levels of cytokines and pentraxin 3 levels in women with unexplained recurrent pregnancy loss and the effect of oral micronized progesterone therapy on cytokine and pentraxin 3 levels and its relation to the pregnancy outcome. | CTRI/2016/09/007278 |
| Progesterone vaginal vs oral progesterone in the natural cycle of thawed embryo transfer luteal support: A multi-center prospective randomized clinical trial | Progesterone vaginal vs oral progesterone in the natural cycle of thawed embryo transfer luteal support: A multi-center prospective randomized clinical trial | ChiCTR-IOR-16009248 |
| Effects of clomiphene citrate on endometrial morphology. | Evaluation of endometrial pinopod concentrations changes during the ovulation induction by Clomiphene citrate plus Estradiol valerate and Clomiphene citrate plus Progesterone comparison with Clomiphene citrate alone among infertile women. | IRCT2015011920408N3 |
| Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants with Previously Untreated Locally Advanced, Inoperable (cannot be removed surgically), or Metastatic (spread to other locations in the body) Triple Negative Breast Cancer (breast cancer that does not have receptors for Oestrogen and progesterone hormones or HER2 proteins). | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1. - ASCENT-03 | EUCTR2021-005743-79-CZ |
| Progesterone in Threatened Abortion | Prospective, Double-blind, Randomised, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of Natural Progesterone 25 mg/Bid Administered Subcutaneously in the Maintenance of Early Pregnancy in Women With Symptoms of Threatened Abortion | NCT02950935 |
| Progesterone in Luteal Phase Deficiency | Prospective, Randomised, Double-blind, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of 25 mg Natural Progesterone Administered Subcutaneously in Restoring the Normal Luteal Phase in Women With Previous Diagnosis of Luteal Phase Deficiency | NCT02950948 |
| To study efficacy and safety of Progesterone SR tablets in patient with secondary amenorrhea | An Open label, Randomized, Multicentric, Parallel group, 4 arm, comparartive phase III study to evaluate the Efficacy and Safety of Progesterone SR oral tablets versus Progesterone oral tablets in women with secondary amenorrhea associated with normal estrogen levels. | CTRI/2016/11/007433 |
| Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) | A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Multifetal Gestation (STTARS) | NCT00099164 |
| A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone versus Crinone intravaginal progesterone gel for Luteal Support in In-Vitro Fertilization (LOTUS II) | A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Crinone 8% intravaginal progesterone gel 90 mg daily for Luteal Support in In-Vitro Fertilization (LOTUS II) - Lotus II | CTRI/2016/01/006490 |
| Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women | Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women | NCT02968342 |
| The Vaginal Progesterone and Cerclage | The Effect of Adjunctive Use of Vaginal Progesterone After Cerclage on Prevention of 2nd Trimester Miscarriage | NCT02846909 |
| Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler | Effect of Progesterone Therapy in Cases With Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler | NCT04426487 |
| Progesterone for Cannabis Withdrawal | Progesterone for the Treatment of Cannabis Withdrawal | NCT03430050 |
| Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole | """Supplementation of the Luteal Phase With Vaginal Progesterone (Crinone 8%) in Women With Polycystic Ovary Syndrome Undergoing Ovulation Induction With Letrozole: A Prospective and Randomized Controlled Trial" | NCT03440359 |
| Comparison of efficacy of oral and vaginal progesterone to prevent preterm birth in pregnant women with short cervix: Randomized controlled trial | Comparison of efficacy of oral and vaginal progesterone to prevent preterm birth in pregnant women with short cervix: Randomized controlled trial | TCTR20190324001 |
| Trial of prevention of preterm birth in pregnancy after abdominal trachelectomy by vaginal progesterone | Trial of prevention of preterm birth in pregnancy after abdominal trachelectomy by vaginal progesterone - Trial of prevention of preterm birth in pregnancy after abdominal trachelectomy by vaginal progesterone | JPRN-jRCTs071180085 |
| Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone | Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone - Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone | JPRN-jRCTs071180084 |
| Progesterone Supplementation in Threatened Abortion | Progesterone Supplementation in Threatened Abortion: Is it a Sound Practice? | NCT03930212 |
| Comparison of the effect of two progesteron drugs in protection of abortion | Comparison of Vaginal Progesterone and Oral Micronized Progesterone on Pregnancy Outcomes in Women with Threatened Miscarriage | IRCT20120104008611N9 |
| Evaluation of progesterone levels at oocyte retrieval and impact on pregnancy outcomes: a retrospective cohort study. | Evaluation of progesterone levels at oocyte retrieval and impact on pregnancy outcomes in women undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI): a retrospective cohort study | ACTRN12619000824167 |
| Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia | Vaginal Micronized Progesterone or Levonorgestrel-releasing Intrauterine System (LNG-IUS) for Treatment of Non-atypical Endometrial Hyperplasia: A Prospective Randomized Trial | NCT03992937 |
| Progesterone Versus Progesterone Plus Dydrogesterone in FET | Micronized Progesterone Versus Micronized Progesterone Plus Dydrogesterone for Luteal Phase Support in Frozen - Thawed Transfer: a Prospective Cohort Study | NCT03998761 |
| Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer | PD-1 Inhibitor Combined With Progesterone Treatment in Early Stage Endometrial Cancer Patients Who Want to Preserve Fertility | NCT04046185 |
| The effect of adding extra rectally progesterone when the serum progesterone level is too low during infertility treatment with thawed embryos. | Optimizing serum progesterone level during luteal phase in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – interventional and observational trial | EUCTR2019-001539-29-DK |
| Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. | Suppression of Endogenous Luteinizing Hormone (LH) Surge With Progesterone vs GnRH Antagonist in Freeze-all IVF Cycles. A Prospective Equivalence Study With Repeated Ovarian Stimulation Cycles. | NCT04108039 |
| The Association Between Serum E2 and P on the Day of FET and the Pregnancy Outcome | The Association Between Serum Estradiol and Progesterone on the Same Day of FET and the Pregnancy Outcome | NCT04114500 |
| A study investigating whether progesterone supplementation in otherwise unmedicated, natural menstrual cycles can improve live birth rates | A Randomised Controlled trial investigating the effects of Progesterone for luteal phase support in Natural Cycles for unexplained infertility - Progesterone in Natural Cycles (PiNC) | EUCTR2019-003468-27-GB |
| Pessary Versus Cerclage With or Without Progesterone in Twins | The Effectiveness of Cervical Pessary Compared to Cervical Cerclage With or Without Vaginal Progesterone for the Prevention of Preterm Birth in Women With a Twin Pregnancy and a Short Cervix: a Two-by-two Factorial Randomised Clinical Trial | NCT03863613 |
| Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles | Comparison of Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles: a Randomized Controlled Trial | NCT04124913 |
| Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses | The Effect of Omega 3 and Vaginal Progesterone on Birth Weight and Doppler Velocimetry of Constitutionally Small for Gestational Age Fetuses. | NCT04161989 |
| A New Hormone Replacement Paradigm: Physiologic Restoration Study | A New Hormone Replacement Paradigm: Physiologic Restoration Using Compounded Biomimetic Estradiol, Progesterone and Testosterone Applied Transdermally in a Rhythmic Dose | NCT04190927 |
| Relative bioavailability study of Progesterone vaginal Suspension with applicator of with Crinone with applicator of Merck Specialities Pvt Ltd in healthy adult postmenopausal Female human subjects under fasting conditions | An Open label,balanced, randomized two-treatment two-period two-sequence single intra-vaginal dose crossover relative bioavailability study of Progesterone vaginal Suspension 12.5% w/v with applicator (4 metered dose) of Lincoln Pharmaceuticals Ltd with Crinone® 8% (progesterone gel) with applicator of Merck Specialities Pvt Ltd in healthy adult postmenopausal Female human subjects under fasting conditions | CTRI/2020/01/022885 |
| Serum Progesterone Level in HRT-FET:a RCT | The Effect of Serum Progesterone Level on Day 3 in HRT-FET Cycles on the Clnical Outcome: a Randomized Controlled Study | NCT04248309 |
| The effect of Dydrogesterone and micronized progesterone on threatend abortion | The comparison between the effect of Dydrogesterone and micronized progesterone intake on consequences of pregnancy in threatend abortion. | IRCT20120104008611N10 |
| Effect of progesterone on uterine and placental vascular resistance in women at risk of preterm birth | Effect of different dosage of progesterone on uterine and placental vascular resistance in women at risk of preterm birth | IRCT20151228025732N48 |
| Impact of Serum Progesterone in Modified Natural Cycles and Stimulated Cycles on Ongoing Pregnancy Rate | Impact of Serum Progesterone Concentration on the Day of Embryo Transfer in Modified Natural Cycles and Stimulated Cycles on Ongoing Pregnancy Rate | NCT04259996 |
| Pessary Versus Progesterone in Singletons | The Effectiveness of Cervical Pessary Versus Vaginal Progesterone for the Prevention of Preterm Birth in Women With Singleton Pregnancies and Short Cervix: a Multicenter Randomized Controlled Trial | NCT04300322 |
| The impact of vaginal progesterone and vitamin D3 on the treatment of unexplained recurrent abortion | Effect of concomitant administration of vaginal progesterone and vitamin D3 in the treatment of unexplained recurrent abortion in pregnant women | IRCT2013100114853N1 |
| A multi-part, clinical study testing the safety and effectiveness of cobimetinib in combination with paclitaxel as initial treatment for patients with triple-negative (HER2 negative, Estrogen receptor negative, and Progesterone receptor negative) breast cancer that has spread. | A MULTISTAGE, PHASE II, STUDY EVALUATING THE SAFETY AND EFFICACY OF COBIMETINIB IN COMBINATION WITH PACLITAXEL AS FIRST-LINE TREATMENT FOR PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER | EUCTR2014-002230-32-ES |
| Comparison between two types of Progesterone in endometrial preparation for Transfer of Thawed Embryos | Comparison between Micronized Vaginal Progesterone and Oral Didrogesterone in endometrial preparation for Transfer of Thawed Embryos | RBR-6qycxj |
| Estradiol levels in early pregnancy after natural, estradiol + progesterone or gonadotrophin stimulated frozen embryo transfer (FET) cycle | Estradiol levels in early pregnancy after natural, estradiol + progesterone or gonadotrophin stimulated frozen embryo transfer (FET) cycle | EUCTR2020-001218-39-DK |
| Progesterone for the Treatment of COVID-19 in Hospitalized Men | A Single Center, Randomized, Controlled Trial of the Safety and Efficacy of Progesterone for the Treatment of COVID-19 in Hospitalized Men | NCT04365127 |
| Progesterone in the Treatment of Acute Hemorrhagic Stroke | An International Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Progesterone Combined Intranasal and Intramuscular Administration in Patients With Acute Hemorrhagic Stroke | NCT04143880 |
| Investigating the relationship between mid-cycle progesterone level and success rate in IuI(Intrauterine sperm injection) cycles. | Investigating the relationship between mid-cycle progesterone level and success rate in IuI(Intrauterine sperm injection) cycles | IRCT20110301005942N5 |
| Dydrogesterone or micronized progesterone related birth defects in children | Congenital anomalies in children following maternal use of dydrogesterone or micronized progesterone as luteal support in infertile women: A retrospective, observational study | ISRCTN55659103 |
| Effect of Cervical Cerclage With Vaginal Progesterone in Asymptomatic Twin Pregnancies With a Sonographic Short Cervix | Effect of Cervical Cerclage With or Without Vaginal Progesterone Versus Vaginal Progesterone Alone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With a Sonographic Short Cervix: A Randomized Clinical Trial | NCT03781466 |
| Prospective, randomised, double-blind, placebo controlled, phase III clinical study assessing the efficacy of 25 mg natural progesterone administered subcutaneously in restoring the normal luteal phase in women with previous diagnosis of luteal phase deficiency. | Prospective, randomised, double-blind, placebo controlled, phase III clinical study assessing the efficacy of 25 mg natural progesterone administered subcutaneously in restoring the normal luteal phase in women with previous diagnosis of luteal phase deficiency. - Progesterone (Pleyris) | EUCTR2016-002731-14-IT |
| Trial of prevention of preterm birth in pregnancy after preterm birth by progesterone | Trial of prevention of preterm birth in pregnancy after preterm birth by progesterone - Trial of prevention of preterm birth in pregnancy after preterm birth by progesterone | JPRN-UMIN000031586 |
| Administration of Vaginal and Rectal Progesterone During FET Cycles | Administration of Vaginal and Rectal Progesterone During Frozen Embryo Transfer Cycles | NCT03470610 |
| Effectiveness of progesterone, Duphaston, and placebo to prevent preterm birth | Effectiveness of progesterone, Duphaston, and placebo to increase gastaional age in preterm labor | IRCT20180303038922N1 |
| Variation of Progesterone in IVF Cycles | Variation of Progesterone in IVF Cycles | NCT03519776 |
| The effect of oral progesterone capsule for luteal phase support on pregnancy rate: a randomized controlled trial | The effect of oral progesterone capsule for luteal phase support on pregnancy rate: a randomized controlled trial | ChiCTR1800015958 |
| Letrozole in increasing endometrial thickness in Premenopausal patient | Comparison of the effect of Letrozole and medroxy progesterone on premenopausal patient with endometrial hyperplasia: Randomized Clinical Trial | IRCT201510244339N12 |
| Vaginal Progesterone for the Prevention of Preterm Birth in Twins | Vaginal Progesterone for the Prevention of Preterm Birth in Twins: A Pilot Randomised, Factorial Designed Trial (POPPET) | NCT03540225 |
| Chinese Herbal Medicine and Micronized Progesterone for threatened miscarriage: An International Cooperation Multicenter Randomized Controlled Trial | Chinese Herbal Medicine and Micronized Progesterone for threatened miscarriage: An International Cooperation Multicenter Randomized Controlled Trial | ChiCTR-IOR-15007526 |
| A study to assess clinical use and safety of once daily natural progesterone in threatened miscarriage cases | dRug Utilization Surveillance study of natural progeSterone SR in Threatened miscarriage: with Luteal phase insufficiency: RUSST analyses - RUSST | CTRI/2018/05/013901 |
| Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures | A Prospective, Multi-Center, Non-Comparative Trial of the Clinical Safety of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology (ART) Procedures | NCT03565211 |
| Relation between consumption of Progesterone and pregnancy in the IUI cycle | The relationship between consumption of Progesterone suppository and pregnancy rate in intrauterine insemination (IUI) method | IRCT20180602039952N1 |
| The clinical study on progesterone administration and endometrial implantation window of endometriosis | The clinical study on progesterone administration and endometrial implantation window of endometriosis | ChiCTR1800017318 |
| Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation | Evaluation of the Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation With Short Cervix: a Double-Blind Randomized Controlled Trial | NCT03781674 |
| Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer Cycles | Oral Dydrogesterone Versus Vaginal Progesterone in the Luteal Phase Support in Cryo-warmed Embryo Transfer Cycles: Randomized Controlled Trial | NCT03619707 |
| Prospective, double-blind, randomised, placebo controlled, phase III clinical study assessing the efficacy of natural progesterone 25 mg/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion. | Prospective, double-blind, randomised, placebo controlled, phase III clinical study assessing the efficacy of natural progesterone 25 mg/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion. - Progesterone (Pleyrys) | EUCTR2016-002777-35-IT |
| Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI | Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study. | NCT03677336 |
| Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series | Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series | ChiCTR1800018526 |
| vaginal progesterone in increased uterine artery doppler findings | comparison of vaginal progesterone and aspirin on increased uterine artery doppler finding in pregnant women aged 16 to 24 weeks | IRCT20101129005272N2 |
| Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX) | A Proof of Concept, Randomized, Controlled Clinical Trial to Assess the Efficacy of Subcutaneous Progesterone (Prolutex) Versus Vaginal Progesterone (Progeffik) for Endometrial Preparation in Women Undergoing Frozen Embryo Transfer(FET) Cycles | NCT03701490 |
| Daytime Profile of Salivary Progesterone | Daytime Profile of Salivary Progesterone During the Mid-luteal Phase of IVF and FET Cycles | NCT03725904 |
| Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support | Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support: Prospective Randomized Trial. | NCT03734770 |
| Impact of Progesterone on Stress Reactivity and Cannabis Use | Impact of Progesterone on Stress Reactivity and Cannabis Use | NCT03729869 |
| Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women | Open-label, Randomized, Clinical Trial With Three Groups for the Characterization of Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women | NCT03737656 |
| A comparative study of the effect of vaginal and pessary progesterone along with the vaginal progesterone in preventing preterm delivery in twin pregnancies of pregnant women | A comparative study of the effect of vaginal and pessary progesterone along with the vaginal progesterone in preventing preterm delivery in twin pregnancies of pregnant women | IRCT20151207025420N2 |
| The effect of progesterone to prevent preterm delivery | The effectiveness of daily rectal progesterone to prevent preterm delivery | IRCT20091023002624N28 |
| Blocking Mifepristone Action With Progesterone | A Randomized Trial of Mifepristone Antagonization With High-Dose Progesterone to Prevent Medical Abortion | NCT03774745 |
| Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa | Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate for Prevention of Emergent Cesarean Delivery in Asymptomatic Pregnant Women With Placenta Previa: A Randomized Controlled Study | NCT03779451 |
| Clinical Study on Endometrial Receptivity | Clinical Study on the Impact of Route of Administration of Progesterone and Endometriosis on Endometrial Receptivity | NCT03687021 |
| Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone | Determinaton of Changes in the Endometrial Gene Expression Profile Induced by Exogenous Progesterone After Post-ovulatory Administration of Mifepristone | NCT06616077 |
| Subcutaneous progesterone ( Prolutex ) versus vaginal progesterone capsules (Progeffik) for endometrial preparation in fresh donated oocyte recipients: A prospective, randomized, single-blind, pilot trial. | Subcutaneous progesterone ( Prolutex ) versus vaginal progesterone capsules (Progeffik) for endometrial preparation in fresh donated oocyte recipients: A prospective, randomized, single-blind, pilot trial. | EUCTR2014-004784-20-ES |
| Effect of Progesterone Administration on Severely Head Injured Patients | Effect of Progesterone Administration on Severely Head Injured Patients: Hospital Based Study | NCT06631547 |
| Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone | Effect of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenic Adolescent Girls (JCM021) | NCT01428193 |
| Progesterone for the Treatment of Cocaine Dependence - 1 | Interactions Between Progesterone and Cocaine in Women | NCT00218257 |
| Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition | Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Normal and Hyperandrogenemic Adolescent Girls (JCM010) | NCT01425541 |
| Evaluation of Progesterone vaginal ring v/s Cu T 380 A IUD in lactating women | Evaluation of a progesterone vaginal ring as a new contraceptive option in India - PVR study | CTRI/2011/07/001874 |
| Australasian Collaborative Trial of Vaginal Progesterone Therapy | Australasian Collaborative Trial of Vaginal Progesterone Therapy | ISRCTN20269066 |
| A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone. | A prospective randomized multicentre study to compare Crinone 8% once daily versus other vaginal progesterone. | EUCTR2005-001248-22-DK |
| Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II | Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial | NCT00247169 |
| Effects of early luteal phase estrogen and progesterone administration on luteolysis in normo-ovulatory women. | Effects of early luteal phase estrogen and progesterone administration on luteolysis in normo-ovulatory women. | NL-OMON22980 |
| Effect of Progesterone on Smoking Behavior in Male and Female Smokers | Progesterone and the Effects of Nicotine | NCT00271206 |
| A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients with Severe Traumatic Brain Injury | A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients with Severe Traumatic Brain Injury | CTRI/2011/07/001861 |
| The effect of progesterone supplementation on pregnancy rates in controlled ovarian stimulation and intrauterine insemination cycles: a randomized prospective trial | The effect of progesterone supplementation on pregnancy rates in controlled ovarian stimulation and intrauterine insemination cycles: a randomized prospective trial | IRCT201104266292N1 |
| Relationship Between Mid-luteal Serum Progesterone Levels to Pregnancy Rates in Assisted Reproductive Techniques (ART) | | NCT01356524 |
| A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Prochieve® 8% Progesterone Gel in Preventing Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Prochieve® 8% Progesterone Gel in Preventing Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery | EUCTR2005-003884-22-CZ |
| In women with threatened miscarriage, does progesterone supplementation increase the likelihood of live birth? | In women with threatened miscarriage, does progesterone supplementation increase the likelihood of live birth? | ACTRN12611000405910 |
| Effect of vaginal progesterone on prevention of preterm delivery and neonatal side effects in women at risk for preterm birth | Effect of vaginal progesterone on prevention of preterm delivery and neonatal side effects in women at risk for preterm birth | IRCT201012273386N2 |
| Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor | Uterine Abdominal Electromyography Measurements Before and After Progesterone Treatments for Preterm Labor | NCT01406197 |
| Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension | Multiple-dose Pharmacokinetic Study of Two Aqueous Suspensions of Estradiol and Progesterone Microspheres (1 mg/20 mg & 0.5 mg/15 mg) for Intramuscular Administration, in Postmenopausal Volunteers. | NCT01293747 |
| Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in IUI cycles stimulated with gonadotrophins: a prospective randomized multicentre study. - Luteal Phase and IUI | Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in IUI cycles stimulated with gonadotrophins: a prospective randomized multicentre study. - Luteal Phase and IUI | EUCTR2010-023867-17-BE |
| Randomized Controlled Trial of Vaginal Progesterone in Women With Threatened Preterm Labor | Pilot Randomized Controlled Trial of Vaginal Progesterone to Prevent Preterm Birth in Women With Threatened Preterm Labor | NCT01286246 |
| a clinical trial of progesterone with or without hypothermia in patients with severe head injury | A Randomized Placebo controlled trial (Factorial design) of Progesterone with or without hypothermia in subjects with acute severe traumatic brain injury. | CTRI/2009/091/000893 |
| Progesterone and Second Trimester Bleeding | The Impact of Progesterone on the Risk of Preterm Birth Among Women With Second Trimester Bleeding. A Double Blind Placebo Controlled Trial | NCT01269450 |
| Effect of progesterone administration on outcome of patients with diffuse axonal injury due to severe head trauma | Effect of progesterone administration on outcome of patients with diffuse axonal injury due to severe head trauma | IRCT201011225230N1 |
| PROGESTERONE USE IN UNEXPLAINED INFERTILITY | THE EFFECTIVENESS OF PROGESTERONE IN INCREASING THE FECUNDABILITY AMONG WOMEN WITH ANOVULATORY AND UNEXPLAINED INFERTILITY:A RANDOMIZED CONTROL TRIAL | PACTR201101000269346 |
| Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies? | Effectiveness of Vaginally Administered Progesterone to Prevent Preterm Delivery in Twin Pregnancies - A Multicentre Randomized Trial | NCT00329914 |
| Progesterone for Postpartum Cocaine Relapse | Progesterone for Postpartum Cocaine Relapse | NCT01249274 |
| Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates | Luteal Phase Support With Progesterone vs Estrogen and Progesterone on Pregnancy Rates in Ovarian Stimulation and Intrauterine Insemination Cycles: a Prospective Randomized Study | NCT01237535 |
| In pregnant women with previous subfertility, does progesterone supplementation decrease the likelihood of miscarriage? | In pregnant women with previous subfertility, does progesterone supplementation decrease the likelihood of miscarriage? | ACTRN12611000401954 |
| Vaginal Progesterone as a Treatment for Women Active Preterm Labor | Vaginal Progesterone in Patients With Active Preterm Labor | NCT01206998 |
| Double blind randomised placebo controlled trial of progesterone for the prevention of preterm birth in twins | Double blind randomised placebo controlled trial of progesterone for the prevention of preterm birth in twins | ISRCTN35782581 |
| Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement | A Phase 2, Single-Center, Open-Label, Randomized, Controlled, Pharmacodynamic Study to Compare DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement | NCT00117468 |
| A cohort study to determine the presence of a corpus luteum in patients undertaking frozen embryo transfer and receiving pre-ovulation progesterone luteal phase support | A pilot cohort study of a progesterone modified natural protocol to determine the presence of a corpus luteum in patients undertaking frozen embryo transfer and receiving pre-ovulation progesterone luteal phase support | ACTRN12624001144505 |
| Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls | Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls (JCM017) | NCT01773772 |
| Acute Effects of Progesterone on LH Pulses During the Follicular Phase (CRM006) | Acute Effects of Progesterone on LH Pulses During the Follicular Phase | NCT01602679 |
| Progesterone effect on threatened abortion | To investigate the possible effect of Progesterone Supp on cytokines endocervical concentration of women at risk of abortion | IRCT201012035294N1 |
| Does progesterone given as luteal phase support and amoxycillin as cervical mucus enhancer increase the likelihood of pregnancy in subfertile women receiving clomiphene citrate for anovulation? | In anovulatory women receiving clomiphene citrate does progesterone given as luteal phase support and amoxycillin given as a cervical mucus enhancer compared to placebo increase the likelihood of pregnancy? | ACTRN12612000174886 |
| A multicenter, randomized, open-label, investigator initiated trial of vaginal compared with intramuscular progesterone for prevention of preterm birth in high risk pregnant women | A multicenter, randomized, open-label, investigator initiated trial of vaginal compared with intramuscular progesterone for prevention of preterm birth in high risk pregnant women | KCT0004006 |
| Assessing the effect of supplemental injectable progesterone on complicated monochorionic diamnionic twin pregnanciy with radiofrequency ablation with cercival length of 25 mm or above on TVS | Assessing the effect of supplemental injectable progesterone on complicated monochorionic diamnionic twin pregnanciy with radiofrequency ablation with cercival length of 25 mm or above on TVS | IRCT20200215046496N1 |
| Comparison of oral and intramuscular progesterone in preterm labor | Comparison of pregnancy outcome following oral and intramuscular progesterone use in preterm labor | IRCT20190623043981N1 |
| Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes | Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes | NCT04807543 |
| Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders | Luteal Phase Support Using Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone Supplementation in High Responders Following GnRHa Triggering - A Prospective Randomized Controlled Trial | NCT04797338 |
| Does progesterone support in luteal phase deficiency help subfertile couples achieve a pregnancy? | In women with unexplained subfertility and luteal phase deficiency, does luteal phase support with progesterone while using a fertility awareness-based charting method when compared to fertility awareness-based charting alone increase the likelihood of pregnancy? | ACTRN12612000166875 |
| effects of Progesterone by vaginal suppository to reduce preterm birth in women at risk | Comparison effects of Progesterone by vaginal suppository and betamimetics to reduce preterm birth in women at risk | IRCT201108286808N2 |
| Primary Progesterone Therapy for Operable Breast Cancer | The Primary Progesterone Therapy for Operable Breast Cancer : A Randomized Controlled Trial | NCT00123669 |
| Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor | Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor | NCT01523483 |
| The Effects of Reproductive Hormones on Mood and Behavior | The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement | NCT00001322 |
| Effects of Raloxifene on Hormone Levels | Assessment of the Effects of Raloxifene on Salivary Estradiol and Progesterone Levels | NCT00026962 |
| Progesterone vs Placebo Therapy for Women With Epilepsy | Phase 3 Study of Progesterone vs Placebo Therapy | NCT00029536 |
| Progesterone for Perimenopausal Night Sweats | Oral Micronized Progesterone for Perimenopausal Vasomotor Symptoms | NCT01464697 |
| effect of oral micronized progesterone for prolongation of pregnancy in arrested preterm labour | ORAL MICRONIZED PROGESTERONE FOR MAINTENANCE TOCOLYSIS AFTER ARRESTED PRETERM LABOUR- A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL | CTRI/2011/10/002043 |
| natural frozen – thawed embryo transfer cycles | effect of progesterone in natural frozen – thawed embryo transfer cycles | IRCT201108044339N6 |
| Progesterone Treatment of Blunt Traumatic Brain Injury | ProTECT: Single Center, Phase II (Pilot), Double Blind, 4:1 Randomized, Placebo Controlled Clinical Trial for Progesterone Treatment of Moderate and Severe Blunt TBI | NCT00048646 |
| Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition | Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Early Pubertal Girls (JCM026) | NCT01428245 |
| Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone | Suppression of Daytime and Nighttime LH Frequency by Progesterone in Early Pubertal Girls With and Without Hyperandrogenemia (JCM024) | NCT01428089 |
| Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone | Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenemic Adolescent Girls (JCM025) | NCT01427595 |
| Vaginal Progesterone to Reduce the Risk of Another Preterm Birth | A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy, Safety, and Tolerability of 8% Progesterone Vaginal Gel in Preventing Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery | NCT00086177 |
| A pilot study to assess the feasibility of a RCT to compare the effectiveness of two different progesterone only pills (POP) on reducing pelvic pain | A pilot study to assess the feasibility of a RCT to compare the effectiveness of two different progesterone only pills (POP) on reducing pelvic pain | ISRCTN42638345 |
| Progesterone Treatment in Female Smokers - 12 | Progesterone Treatment in Female Smokers | NCT00000295 |
| Oral Progesterone for Prevention of Preterm Birth | Prevention of Recurrent Preterm Birth With Micronized Progesterone | NCT01180296 |
| Early Progesterone Cessation After in Vitro Fertilization | Early Progesterone Cessation After in Vitro Fertilization | NCT01177904 |
| Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study | Randomized, Controlled, Open-label, Parallel, Clinical Trial to Assess Pharmacokinetics and Endometrial Effect of an Injectable Formulation of Progesterone Microspheres in Doses of 50 mg, 100 mg, 200 mg and 300 mg, in Postmenopausal Women. | NCT01176175 |
| Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone?) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF). | Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone?) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF). | EUCTR2007-006595-11-DE |
| Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects | | NCT01636336 |
| Vaginal Progesterone Versus Placebo in Multiple Pregnancy | Pilot Randomized Trial of Vaginal Progesterone to Prevent Preterm Birth in Multiple Pregnancy | NCT00343265 |
| Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect | Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect | NCT01589081 |
| Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant Drugs | | NCT01589068 |
| Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers | | NCT00377923 |
| Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial | Randomised Study to Examine the Effectiveness of Progesterone in Preventing Severe Preterm Delivery | NCT00422526 |
| Postmenopausal Women Estrogen and Progesterone Infusion | Effect of Age on Gonadotropin Responses to Short-Term Negative and Positive Feedback Effects of Gonadal Steroids Using PET Scanning | NCT00455741 |
| Does Hormonal Luteal Support After Intra-uterine Insemination (IUI) Increase the Pregnancy Rate? | Luteal Support With Vaginal Progesterone Capsules Following Ovulation Induction With Human Menopausal Gonadotropins (hMG) for Intra Uterine Insemination: A Comparative Study | NCT00700492 |
| Natural Progesterone and Preterm Birth in Twins | Eficacia de Los Suplementos de Progesterona Natural en la prevención Del Parto pretérmino Gemelar | NCT00480402 |
| Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women | Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women | NCT00530582 |
| Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor | Prevention of Preterm Delivery With Vaginal Progesterone in Women With Preterm Labor | NCT00536003 |
| Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia | Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia in Patients With a Prior History of Preeclampsia: A Prospective, Randomized Clinical Trial | NCT00719537 |
| Evaluating the effects of progesterone on neurologic outcome of the patients with severe traumatic brain injury | Evaluating the effects of progesterone on neurologic outcome of the patients with severe traumatic brain injury | ACTRN12607000545460 |
| Feasibility Study Into the Contraceptive Effect of Estetrol | A Feasibility Study Into the Contraceptive Effect of Estetrol Alone or Combined With Either Progesterone or Desogestrel by Daily Oral Administration to Healthy Female Volunteers for 28 Days. | NCT00563472 |
| Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism | Role of Estrogen/SERMS on Cardiac Fatty Acid Metabolism (Aim #1- Human Studies) | NCT00565916 |
| Comparing IM vs. Vaginal Progesterone for Pre-term Birth | Comparing Intramuscular Versus Vaginal Progesterone for Prevention of Preterm Birth. | NCT00579553 |
| A clinical study of progesterone for acute craniocerebral injury | A multicenter, randomized double blinding, large scale, placebo controlled, prospective clinical study of progesterone for acute craniocerebral injury | ChiCTR-TRC-08000174 |
| Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues | Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues | NCT00585520 |
| Determining How Quickly Progesterone Slows LH Pulse Frequency | Determining the Rapidity With Which Exogenous P Suppresses Daytime LH (GnRH) Pulse Frequency in Women During the Follicular Phase of the Menstrual Cycle | NCT00594217 |
| PREGNANT Short Cervix Trial | The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)] | NCT00615550 |
| Does progesterone prophylaxis to prevent preterm labour improve outcome? - a randomised double blind placebo controlled trial (OPPTIMUM) - OPPTIMUM | Does progesterone prophylaxis to prevent preterm labour improve outcome? - a randomised double blind placebo controlled trial (OPPTIMUM) - OPPTIMUM | EUCTR2007-007950-77-GB |
| Progesterone Treatment for Cocaine-dependent Women: A Pilot Study | Progesterone Treatment for Cocaine-dependent Women: A Pilot Study | NCT00632099 |
| Vaginal PROgesterone as Maintenance Treatment After an epISode of prEterm Labor (PROMISE Study) | Vaginal Progesterone as a Maintenance Treatment in Women With Previous Preterm Labor. Randomized, Double Blinded, Placebo-controlled Trial | NCT00646802 |
| Estimating the therapeutic effect of 17 alpha-hydroxy progesterone caproate in preventing preterm labor after inhibiting uterine contractions | Estimating the therapeutic effect of 17 alpha-hydroxy progesterone caproate in preventing preterm labor after inhibiting uterine contractions | IRCT2015050119396N3 |
| Effects of early luteal phase vaginal progesterone supplementation on the outcome of in-vitro fertilization and embryo transfer | Effects of early luteal phase vaginal progesterone supplementation on the outcome of in-vitro fertilization and embryo transfer | ACTRN12608000200381 |
| PHASE II STUDY OF DASATINIB (BMS-354825) IN ADVANCED BREAST CANCER RECEPTORS OF ESTROGEN / PROGESTERONE OR HER2 / NEU POSITIVE | PHASE II STUDY OF DASATINIB (BMS-354825) IN ADVANCED BREAST CANCER RECEPTORS OF ESTROGEN / PROGESTERONE OR HER2 / NEU POSITIVE | PER-080-07 |
| Investigation into the effectiveness of progesterone prevention of preterm labour in women who became pregnant by in vitro fertilisation (IVF)/ intra-cytoplasmic sperm injection (ICSI) | Effect of progesterone administration on the duration of pregnancy after in vitro fertilisation (IVF)/ intra-cytoplasmic sperm injection (ICSI): a prospective randomised study | ISRCTN06959967 |
| Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms. | Comparative Efficacy and Safety Study of Three Different Doses of a Formulation Composed of Crystalline Estradiol and Progesterone Microspheres, Indicated for Monthly IM Injection for the Treatment ot Climacteric Symptoms. | NCT00775242 |
| use of progesterone in prevention of preterm labour | RANDOMISED TRIAL OF NATURAL PROGESTERONE IN PREVENTION OF PRETERM BIRTH IN HIGH RISK WOMEN. | CTRI/2008/091/000218 |
| A Prospective, Open Label, Randomised, Parallel Group Trial Comparing the Effects of Highly Purified Menotrophin and Recombinant Follicle Stimulating Hormone (rFSH, Follitropin alpha) Administered Subcutaneoulsy to Subfertile Female Patients Undergoing IVF Using Antagonist Down-Regulation on Progesterone Serum Levels During the Follicular Phase and their Possible Use as Predictors for the Success Rate of Ongoing Pregnancies (PREDICT) - PREDICT | A Prospective, Open Label, Randomised, Parallel Group Trial Comparing the Effects of Highly Purified Menotrophin and Recombinant Follicle Stimulating Hormone (rFSH, Follitropin alpha) Administered Subcutaneoulsy to Subfertile Female Patients Undergoing IVF Using Antagonist Down-Regulation on Progesterone Serum Levels During the Follicular Phase and their Possible Use as Predictors for the Success Rate of Ongoing Pregnancies (PREDICT) - PREDICT | EUCTR2010-019411-37-DE |
| A Single Arm Phase II Study of the Efficacy of Tamoxifen in Triple Negative (oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but Oestrogen Receptor Beta Positive Metastatic Breast Cancer | Women over 18 years with Triple Negative (oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but Oestrogen Receptor Beta Positive Metastatic Breast Cancer will be treated with Tamoxifen to assess the efficacy of this treatment | ACTRN12610000506099 |
| Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes | The Effect of Progesterone Supplementation During Early Gestations in Patients Treated With Rec FSH/GnRH Antagonist:a Randomized Controlled Trial | NCT01147770 |
| Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury | A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury | NCT01143064 |
| Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus | Efficacy of a Topic Therapy With Progesterone Compared to the Conventional Therapy With Clobetasol Propionate in Patients With Vulvar Lichen Sclerosus. A Double Blind, Randomized Phase II Pilot Study. | NCT01126255 |
| Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs | Comparison of the Effectiveness of Micronized Vaginal Progesterone (Endometrin, Ferring) Vs. Progesterone in Oil for Luteal Phase Support in Donor Egg Recipient IVF Cycles Utilizing Previously Vitrified Donor Oocytes | NCT01465373 |
| Effect Of Micronised Progesterone On Endometrial Receptivity | Investigation Of Endometrial Receptivity Parameters At Mid Secretory Phase When Micronised Progesterone Added During Luteal Phase in infertile Patients with Polycistic Ovaries and Unexplained Infertility | ACTRN12610000195055 |
| A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET) | An Open, Randomized, Comparative, Phase III Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET) | NCT01081652 |
| Compare the Difference of P4 Concentration in Serum and Endometrium After Vaginal and IM P Administration | Investigation of the Differences of Progesterone Concentration in Serum and Endometrium After Administration With Vaginal and Intramuscular Progesterone | NCT01057511 |
| Progesterone Support of FET | Progesterone Support for Frozen Embryo Transfer: Intramuscular Versus Vaginal Suppository - A Prospective, Randomized, Controlled Trial | NCT01058382 |
| Prophylactic Administration of Natural Progesterone in the Prevention of Preterm Delivery in Twin Pregnancies | Prophylactic Administration of Natural Progesterone in the Prevention of Preterm Delivery in Twin Pregnancies: A Randomized, Double-Blind, Placebo-Controlled Trial | NCT01031017 |
| Women*s Hormonal Intervention Study in early Postmenopause of Estradiol-progesterone Replacement therapy - effects on quality of life | Women*s Hormonal Intervention Study in early Postmenopause of Estradiol-progesterone Replacement therapy - effects on quality of life - WHISPER-1 | NL-OMON34966 |
| Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus | the Therapeutic Effect Treated With Tamsulosin After ESWL in Urinary Calculus | NCT01010048 |
| Progesterone replacement for prevention of adrenal insufficiency in extremely preterm infants | Progesterone replacement for prevention of adrenal insufficiency in extremely preterm infants - Progesterone replacement in extremely preterm infants | JPRN-UMIN000002268 |
| Women*s Hormonal Intervention Study in early Postmenopause of Estradiol-progesterone Replacement therapy - effects on quality of life | Women*s Hormonal Intervention Study in early Postmenopause of Estradiol-progesterone Replacement therapy - effects on quality of life - WHISPER-1 | NL-OMON34007 |
| Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial | Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial | NCT00946088 |
| The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-Trial | The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-Trial | EUCTR2008-007498-19-CZ |
| PP13 and Doppler Study to Predict Preeclampsia | Combined Sonographic Examination and Placenta Protein 13 (PP13) to Compare the Risk for Development of Preeclampsia Among Among Pregnant Women With and Without a History of Preterm Delivery and Those Treated by Progesterone or Clexane | NCT00928213 |
| Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism | Study to Assess Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism | NCT00929006 |
| Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen | Efficacy & Tolerability of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen Replacement Therapy - Phase II Comparative Study | NCT00919919 |
| Progesterone in recurrent miscarriages (PROMISE) study | First trimester progesterone therapy in women with a history of unexplained recurrent miscarriages: a randomised double-blind placebo-controlled multi-centre trial (The PROMISE [PROgesterone in recurrent MIScarriagE] Trial) | ISRCTN92644181 |
| Evaluation of the effect of vaginal Progesterone in preventing preterm labor | Evaluation of the effect of vaginal Progesterone in preventing preterm labor | IRCT138706051096N1 |
| Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF) | Efficacy and Tolerability of Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF) | NCT00827983 |
| Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF) | Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) Versus Vaginal Progesterone for Luteal Phase Support in Patients Undergoing In Vitro Fertilization (IVF) | NCT00828191 |
| Progesterone for the Treatment of Traumatic Brain Injury III | Phase 3 Clinical Trial to Determine if Progesterone Along With Standard Medical Care for Brain Injury is More Effective at Limiting the Amount of Damage Cause by a Traumatic Brain Injury Than Standard Medical Care Alone. | NCT00822900 |
| The Use of Progesterone to Reduce Preterm Birth | The Use of Progesterone to Reduce Preterm Birth | NCT00830765 |
| Duration of luteal phase support with progesterone pessaries to improve the success rate in assisted reproduction cycles. A prospective randomised control trial. - DOLS | Duration of luteal phase support with progesterone pessaries to improve the success rate in assisted reproduction cycles. A prospective randomised control trial. - DOLS | EUCTR2006-000599-33-GB |
| Effects of progesterone on uterine vascular flow in pregnant women | Evaluation of progesterone administration effects on uterine vascular flow in pregnant women with intrauterine growth restriction fetus and preterm labor | IRCT201203289338N1 |
| Comparison the effect of Gonadotropin releasing hormone agonist administration versus vaginal Progesterone on serum progesterone in luteal phase in ovarian hyperstimulation and intrauterine insemination cycles in unexplained infertility | Comparison the effect of Gonadotropin releasing hormone agonist administration versus vaginal Progesterone on serum progesterone in luteal phase in ovarian hyperstimulation and intrauterine insemination cycles in unexplained infertility | IRCT201205159762N1 |
| Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer | Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer. | NCT01608451 |
| Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndrome | Evaluation of efficacy of vaginal progesterone on pregnancy rate in women with polycystic ovarian syndrome using combination therapies for ovulation induction | IRCT201206072967N4 |
| Subcutaneous progesterone versus vaginal suppository for luteal phase support in assisted reproductive technology cycles in patients referred to Royan Institute | Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial study phase 3 | IRCT201402191141N18 |
| Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients | Subcutaneous Progesterone (Prolutex) Versus Vaginal Progesterone Capsules (Progeffik) for Endometrial Preparation in Fresh Donated Oocytes Recipients: a Randomised, Prospective, Single-blind, Pilot Study | NCT02363127 |
| Lactoferrin or Progesterone for Prevention of Preterm Delivery | Lactoferrin or Progesterone for Prevention of Preterm Delivery | NCT02372942 |
| RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix | A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Nulliparous Women With a Short Cervix | NCT00439374 |
| effect of progestron in preterm labor | Comparing the efficacy of vaginal progesterone (cyclogest) versus injection of 17a hydroxyprogesterone caproate ( proluton) in preventing of preterm brth less than 34 weeks gestation in pregnant women with threatend abortion in Arash Hospita | IRCT2014123120504N1 |
| Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth | | NCT02350231 |
| 17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor | | NCT00809939 |
| Effects of metformin in the treatment of endometrial hyperplasia | The effect of adding metformin to progesterone in patients with endometrial hyperplasia admitted to Arash hospital, Tehran, Iran | IRCT2014082018866N1 |
| Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix | Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix | NCT02338830 |
| Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer | Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer | NCT02323347 |
| Effect of progesterone on pregnancy rate of assisted reproduction | Comparison of oral progesterone with vaginal and subcutaneous progesterone for luteal phase support on pregnancy rate of infertile patients underwent intracytoplasmic sperm injection- Embryo transfer cycles | IRCT2014071212494N2 |
| Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial. | Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial. | NCT01050647 |
| Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support | Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Gonadotropin Ovarian Stimulation for Intrauterine Insemination: a Pilot Randomized Controlled Study | NCT02316626 |
| Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short Cervix | Comparing a Double Dose of Vaginal Progesterone to no Treatment for the Prevention of Preterm Birth in Twins Pregnancy and Short Cervix | NCT02329535 |
| Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women | A Multicenter, Randomized, Open-label, Investigator Initiated Trial of Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women | NCT02304237 |
| Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM) | 17-alpha-Hydroxyprogesterone Caproate (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM), Double-blinded Randomized Clinical Trial | NCT01119963 |
| Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women | Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women | NCT02272647 |
| EVALUATION OF PROGESTERONE-RELATED COMPOUNDS FOR THE TERZIARY PROPHILAXYS OF PRETERM DELIVERY: A MULTICENTRE RANDOMIZED CONTROLLED TRIAL - PROGESTERONE-RELATED COMPOUNDS AND PRETERM DELIVERY | EVALUATION OF PROGESTERONE-RELATED COMPOUNDS FOR THE TERZIARY PROPHILAXYS OF PRETERM DELIVERY: A MULTICENTRE RANDOMIZED CONTROLLED TRIAL - PROGESTERONE-RELATED COMPOUNDS AND PRETERM DELIVERY | EUCTR2009-017441-63-IT |
| Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial: PRogesterone In Spontaneous Miscarriage Trial) | Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial: PRogesterone In Spontaneous Miscarriage Trial) - PRISM: PRogesterone In Spontaneous Miscarriage | EUCTR2014-002348-42-GB |
| The influence of initiation of progesterone supplementation in IVF-ET outcome-a prospective, randomized, controlled trial. | The influence of initiation of progesterone supplementation in IVF-ET outcome-a prospective, randomi | ChiCTR-IPR-14005293 |
| Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer | A Randomized, Three-armed, Non-Inferiority Study of Vaginal Progesterone (Endometrin®) Compared to Intramuscular Progesterone in Oil (PIO) in Infertile Subjects Undergoing Frozen Embryo Transfer (FET) | NCT02254577 |
| Micronised progesterone versus dydrogesterone: A randomised controlled trial | Progestogen for threatened miscarriage: A randomised controlled trial comparing micronised progester | ChiCTR-IPR-14005251 |
| Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery | A Randomized, Open-Label, Controlled, Multi-Center Study on the Efficacy of a Sustained Release Progesterone Cerclage Cervical Pessary at Doses of 6.3 g or 7.7 g for the Prevention of Preterm Birth and a Maximum Duration of 20 Weeks. | NCT02225353 |
| Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone | Use of 17a Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor During Current Pregnancy. Double Blind, Randomized, Controlled Trial. | NCT01317225 |
| A comparison between oral Dydrogestrone with intramuscular and vaginal Progesterone in frozen embryo transfer in IVF cycles. | A comparison between oral Dydrogestrone with intramuscular and vaginal Progesterone for luteal phase support in IVF , frozen embryo transfer cycles. | IRCT201406255181N15 |
| Progesterone for First Trimester Vaginal Bleeding | The Impact of Progesterone Treatment on Obstetrical Outcome Among Women With First Trimester Vaginal Bleeding | NCT01501890 |
| 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographic short cervix | 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographic short cervix in ARASH hospital during 2012-2013 years | IRCT2012082610664N1 |
| Cervical Cerclage as a Rescue Procedure after Progesterone Failure in Women with Progressive Cervical Shortening. | Cervical Cerclage as a Rescue Procedure for prevention of pre-term labor after Progesterone Failure in Women with Progressive Cervical Shortening. | ACTRN12615000209594 |
| Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women | Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women | NCT02224313 |
| SuPPoRT: Stitch, Progesterone or Pessary: a Randomised Trial | The prevention of pre-term birth in women who develop a short cervix. A multi-centre randomised controlled trial to compare three treatments; cervical cerclage, cervical pessary and vaginal progesterone. - SuPPoRT: Stitch,Progesterone or Pessary: a randomised controlled trial | EUCTR2015-000456-15-GB |
| Study of blood sugar levels in pregnant women on progesterone therapy for prevention of preterm labour versus control group | Study of blood sugar levels in pregnant women on progesterone therapy for prevention of preterm labour versus control group | PACTR201505001094636 |
| Study on the feasibility and safety of sequential therapy of estrogen and progesterone in the treatment of incomplete abortion | Analysis of the therapeutic effect of a combination drug regimen based on sequential therapy of estrogen and progesterone in the treatment of incomplete abortion | ChiCTR2400090600 |
| Progesterone-modified Natural Cycle for FET | Comparison of Progesterone-modified Natural Cycle and Hormone Replacement Therapy Cycle for Endometrial Preparation in Single Frozen Blastocyst Transfer | NCT06644794 |
| Response of patient of threatened abortion to two oral forms of progesterone | Comparison between Oral Dydrogesterone and Oral Micronized Progesterone in Threatened Abortion : A randomized controlled trial - NIL | CTRI/2024/10/075727 |
| A Randomized Controlled Trial Comparing the Efiicacy of Oral Micronized Progesterone at 200 Miligrams per Day Versus 600 Miligrams per Day for Tocolytic Effect Maintenance in Preterm Labor | A Randomized Controlled Trial Comparing the Efiicacy of Oral Micronized Progesterone at 200 Miligrams per Day Versus 600 Miligrams per Day for Tocolytic Effect Maintenance in Preterm Labor | TCTR20241028003 |
| Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert | An Open-Label, Four-Treatment, Parallel Study of the Comparative Pharmacokinetics of a Progesterone Intravaginal Ring (IVR) 8 Mg and 12 Mg/day Versus Progesterone Vaginal Insert 100mg | NCT06668896 |
| Progesterone in Gender Affirming Hormone Therapy Study | Effects of Oral Progesterone in Transgender Women on Breast Development, Sleep Quality, Psychological Distress, and Cardiovascular Risk | NCT06807580 |
| Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women with Polycystic Ovarian Syndrome | Progesterone Primed Ovarian Stimulation Versus Gonadotrophin-Releasing Hormone Antagonist in Women with Polycystic Ovarian Syndrome | NCT06812559 |
| Role of Low Dose Injectable Progesterone in Triggering Ovulation | Role of Low Dose Injectable Progesterone in Triggering Ovulation: A Randomized Controlled Trial | NCT06928844 |
| Prevention of preterm birth in twin pregnancies - “Randomised trial of progesterone versus placebo” | Early vaginal progesterone for the preVention of spontaneous prEterm birth iN TwinS: A randomised, placebo controlled, double-blinded trial- EVENTS | ISRCTN66445401 |
| Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome | Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome: A Non-randomized Prospective Trial (The BOOST Study) | NCT06834594 |
| Establishing effect of mifepristone in induction of labour | Effect of mifepristone on serum progesterone levels and bishop score in induction of labour - NIL | CTRI/2025/02/080799 |
| Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth | Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth : A Randomised Clinical Trial | NCT06975943 |
| The Efficacy of Progesterone in Treatment of Traumatic Optic Neuropathy. | The Efficacy of Progesterone in Treatment of Traumatic Optic Neuropathy. | TCTR20151118001 |
| Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment | Vaginal Administration of Alpha Lipoic Acid vs Progesterone for the Subchorionic Hematoma Treatment | NCT02601898 |
| Hormones and Reduction in Co-users of Marijuana and Nicotine | Sex Differences and Progesterone: Association With Impulsivity and Marijuana Reduction in Co-Users of Marijuana and Nicotine Cigarettes | NCT02579421 |
| The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth | The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth | NCT02571296 |
| Comparison Between Natural Progesterone and Vaginal Pessary for the Prevention of Spontaneous Preterm Birth | Comparison Between Natural Progesterone and Vaginal Pessary for the Prevention of Spontaneous Preterm Birth in Pregnant Women With a Uterine Cervix Measuring 25 mm or Less in Length | NCT02511574 |
| Intramuscular versus vaginal progesterone in vitrified -warmed embryo transfer cycles | Intramuscular versus vaginal progesterone in vitrified -warmed embryo transfer cycles | PACTR201705001176205 |
| A randomized, cross-over study comparing the pharmacokinetics and endometrial effects of daily subcutaneous injection of 25mg and 50mg progesterone II | A randomized, cross-over study comparing the pharmacokinetics and endometrial effects of daily subcutaneous injection of 25mg and 50mg progesterone II | ChiCTR2500102276 |
| Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial | Cervical Pessary vs. Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial | NCT02470676 |
| Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy | Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy - a Double Blind Randomized Control Trial | NCT02460302 |
| A randomized multicentre study comparing the effectiveness, safety and tolerance of daily oral dygesterone against Crinone gel for use in in-vitro fertilization (IVF) | A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Crinone 8% intravaginal progesterone gel 90 mg daily for Luteal Support in In-Vitro Fertilization (LOTUS II) - LOTUS II | EUCTR2012-002993-29-BE |
| the effect of progesterone in the prevention of preterm delivery | Comparison of the Effects of Vaginal Progesterone (Cyclogest) and Intramuscular Progesterone (Hydroxyprogesterone Caproate) in the Prevention of Preterm Labor | IRCT2015040921670N1 |
| Comparison of intramuscular progesterone and suppository progesterone for luteal phase support in IUI cycles | Comparing intramuscular(25 and 50 milligram) and vaginal suppository(400 and 800 milligram) progesterone for luteal phase support in IUI cycle in infertile women with age of 20 to 38 years, who were candidate for IUI cycles due to male factor and unexplained infertility. | IRCT2015030521344N1 |
| Clinical trial to evaluate the efficacy of progesterone given to patients with different dose by puncture than by vaginal in the preparation of the uterus finalized in medically assisted reproduction with thawed embryos | Pilot clinical study multicenter, prospective, randomized, open, non-profit to evaluate the efficacy of progesterone administered with different dose subcutaneously compared to progesterone administered by Vaginal in Endometrial preparation aimed at transfer of embryos underwent previous cryopreservation - Pro.V.En | EUCTR2014-005474-11-IT |
| Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor | Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor - Randomized Double Blind Placebo Controlled Trial | NCT02430233 |
| Study to compare the endometrial transformation with 25 mg / day of subcutaneous progesterone(Prolutex) versus 50 mg / day intramuscular progesterone (Prontogest) | Randomized Clinical Trial comparing the endometrial transformation with 25 mg/day of subcutaneous progesterone (Prolutex) versus 50 mg/day intramuscular progesterone (Prontogest) | EUCTR2015-000290-12-ES |
| A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix | A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix | NCT02518594 |
| Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage | | NCT01670929 |
| The effect of rectal progesterone on labor, and the prevention of preterm delivery, as well as minimizing the maternal and prenatal complications due to Preterm Premature Rupture Of Membrane (PPROM) | The effect of rectal progesterone on the latency period as well as maternal and prenatal outcome in PPROM between 24-33+6 Weeks | ISRCTN65694106 |
| Effect on the endometrial thickness of progesterone 25 mg solution administered by oral route in post-menopausal women under treatment with estrogens, compared to progesterone 200 mg capsules. | Effect of a progesterone 25 mg solution (Pleyris, IBSA Farmaceutici Italia, srl) administered by oral route compared to an oral progesterone 200 mg capsule (Prometrium, Rottapharm SpA) on the endometrial thickness of post-menopausal women under hormone replacement therapy. A pilot, prospective, open-label, randomised, three arm, parallel-group, single centre, phase II clinical trial. | EUCTR2014-001185-10-IT |
| Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening | Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes | NCT01929083 |
| Preterm Delivery Prevention in Twins With Progesterone | Prevención de Parto Prematuro en Gemelares: Ensayo Aleatorio Con Progesterona Vaginal. | NCT01927029 |
| Neo-adjuvant Progesterone and Vitamin D3 in Breast cancer | Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in women with LOBC and LABC - Feasibility Study | CTRI/2013/06/003788 |
| Comparison of oral dydrogestrone with vaginal progesterone | Comparison of oral dydrogestrone with vaginal progesterone for luteal-phase support in IVF | IRCT2013050713265N1 |
| Clinical trial of nicotinamide combined with estrogen and progesterone on primary ovarian insufficiency | Clinical trial of nicotinamide combined with estrogen and progesterone on primary ovarian insufficiency | ChiCTR2000035390 |
| Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization. | Randomized Clinical Trial to Compare the Pregnancy Rates of Vaginally Applied Cyclogest® Pessary and Crinone® 8% Gel After In-vitro Fertilization | EUCTR2013-001105-81-HU |
| The effect vitamin C supplementation on infertile women with polycystic ovary syndrome | The comparison of the effectiveness of vitamin C supplementation with balance diet, versus Placebo on the Luteinizing hormone, follicle-stimulating hormone, Dehydroepiandrosterone, testosterone, estradiol, progesterone and sex hormone-binding protein in infertile women with polycystic ovary syndrome | IRCT2013030312672N1 |
| Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor | Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor | NCT01840228 |
| A study to compare if 30mg of oral Dydrogesterone is as good, tolerable and safe as 600mg of intravaginal capsules for luteal support in IVF pregnancies. This study will be conducted at several study sites and neither the patient or the doctor will know which of the two different treatments a patient will receive. | A Double-Blind, Double-Dummy, Randomized, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Intravaginal Micronized Progesterone Capsules 600 mg daily for Luteal Support in In-Vitro Fertilization - Lotus I | EUCTR2012-002215-26-BE |
| The effect of vitamin D3 administration in endometrium of patients with recurrent implantion failure | The effect of vitamin D3 administration on gene expression and protein levels of progesterone receptors, VDR and and endometrial decidualization factors(IGFBP1, PRL, HOXA10) in endometrium of patients with recurrent implantion failure | IRCT20220528055006N1 |
| Vaginal Progesterone in Twins With Short Cervix | Vaginal Progesterone to Prevent Early Preterm Birth In Twin Pregnancy With Short Cervix. Double-Blind, Placebo-Controlled, Randomized Clinical Trial | NCT01812239 |
| A randomized controlled trial study on the effectiveness of 17 alpha hydroxyprogesterone and micronised progesterone in preventing preterm labor of pregnant women with arrested premature labor. | A randomized controlled trial study on the effectiveness of 17 alpha hydroxyprogesterone and micronised progesterone in preventing preterm labor of pregnant women with arrested premature labor. | TCTR20210407003 |
| Progesterone Effect on Individuals Diagnoses With AD and PTSD. | Progesterone Treatment in Reducing Trauma and Alcohol Induced Craving in Individuals Diagnoses With Alcohol Dependence (AD) and Post-tramatic Stress Disorder (PTSD). | NCT02187224 |
| Effect of proluton and cyclogest on perinatal outcome | Comparing the efficacy of 17a hydroxyprogesterone caproate ( proluton) versus vaginal progesterone (cyclogest) on perinatal outcome in high risk patients who undergo cerclage | IRCT20181107041585N4 |
| Randomized clinical trial for the local therapy of carpal tunnel syndrome: cortisone vs progesterone - STC- Progesterone -2007 | Randomized clinical trial for the local therapy of carpal tunnel syndrome: cortisone vs progesterone - STC- Progesterone -2007 | EUCTR2007-006515-23-IT |
| Does Oral Micronized Progesterone Shorten Time of Symptoms From Concussion | Micronized Oral Progesterone and Effect on Time Symptomatic From Concussion: A Pilot Study | NCT01809639 |
| Intrauterine Insemination and Luteal Fase Support | Impact of Luteal Phase Support With Vaginal Progesterone on the Clinical Pregnancy Rate in Intrauterine Insemination Cycles Stimulated With Gonadotrophins: a Prospective Randomized Multicentre Study. | NCT01826747 |
| Progesterone & Postpartum Relapse to Smoking | Progesterone & Postpartum Relapse to Smoking | NCT01798394 |
| Comparison of uterine blood flow, following two types of progesterone in recurrent miscarriage | Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent spontaneous miscarriage | CTRI/2013/02/003406 |
| A clinical trial to Investigate the Efficacy of Progesterone in Patients with Severe Traumatic Brain Injury. | A Randomized, Placebo-Controlled Study to Investigate the Efficacy of Progesterone in Patients with Severe Traumatic Brain Injury. | CTRI/2013/02/003396 |
| The importance of progesterone level at day of human chorionic gonadotropin (hCG) administration on pregnancy rate in the short-term protocol | Evaluation of relationship between progesterone level at the day of human chorionic gonadotropin administration and pregnancy rate. | ACTRN12613000082707 |
| Effect of progestrone on head injury | Evaluation of improved outcomes from the administration of progesterone after severe traumatic brain injury | IRCT2012080810536N1 |
| Progesterone and Atomoxetine for Cocaine Cessation | Progesterone and Atomoxetine for Cocaine Cessation | NCT01741376 |
| A randomised controlled trial to compare the effect of 2 progesterones on the vascular elasticity, lipid profiles and coagulation cascade (clotting factors) of women with premature ovarian failure. | A randomised controlled trial to compare the effect of micronized progesterone and Medroxyprogesterone Acetate on the vascular elasticity, lipid profile and coagulation cascade of women with premature ovarian failure. - Effect of progestogens on cardiovascular health in women with POF (01) | EUCTR2012-004511-30-GB |
| Sex Differences, Hormones & Smoking Cessation | Sex Differences & Progesterone: Association With Impulsivity and Smoking Cessation | NCT01744574 |
| Progesterone and Brain Imaging Study | Multimodal Imaging of Progesterone/Neurosteroid Effects in Nicotine Addiction | NCT01954966 |
| Progesterone in Expectantly Managed Early-onset Preeclampsia | Efficacy of 17-Hydroxyprogesterone Caproate in Expectantly Managed Early-onset Preeclampsia: A Randomized Controlled Study | NCT04077853 |
| Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone | Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone | NCT01940653 |
| A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms | A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus | NCT01942668 |
| Progesterone for Smoking Relapse Prevention Following Delivery | Progesterone for Postpartum Smokers: Feasibility, Breastfeeding and Infant Safety | NCT01972464 |
| Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial | Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial | NCT02145767 |
| Randomized Trial of Maternal Progesterone Therapy | Randomized Trial of Maternal Progesterone Therapy to Improve Neurodevelopmental Outcomes in Infants With Congenital Heart Disease | NCT02133573 |
| Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome | Prognostic Value of Progesterone Levels on Oocyte Retrieval Day for Outcome of Intracytoplasmic Sperm Injection | NCT02109900 |
| A Multicenter, Placebo-controlled, Double-blind, Randomized, Parallel-group Study Assessing Efficacy of Progesterone Vaginal Tab for Prevention of Preterm Delivery | A Multicenter, Placebo-controlled, Double-blind, Randomized, Parallel-group Study Assessing Efficacy of Progesterone Vaginal Tab for Prevention of Preterm Delivery - Trial Of Progesterone vaginal tab In prevention of preterm delivery evaluated by CervicAl Length (TROPICAL Study) | JPRN-UMIN000013518 |
| The exogenous progesterone free luteal phase after GnRHa trigger – a randomized controlled pilot study in high-responder IVF patients | The exogenous progesterone free luteal phase after GnRHa trigger – a randomized controlled pilot study in high-responder IVF patients | EUCTR2014-000448-13-DK |
| The exogenous progesterone free luteal phase after GnRHa trigger – a randomized controlled pilot study in normo-responder IVF patients | The exogenous progesterone free luteal phase after GnRHa trigger – a randomized controlled pilot study in normo-responder IVF patients | EUCTR2014-000447-32-DK |
| Effect of the progesterone injection in prevention of preterm labour | Effect of the 17 alpha hydroxy progesterone caproate in prevention of preterm labour in high risk pregnant women | IRCT2014101019222N2 |
| Comparison of two ways of delivering a drug (progesterone) to prevent another preterm delivery, one by an injection and other through the vagina | Comparison of vaginal and intramuscular routes of progesterone delivery in prevention of preterm delivery in women with prior preterm birth | CTRI/2015/01/005467 |
| comparison of the psychological effects of vaginal versus intramuscular progesterone administration | psychological effects of vaginal versus intramuscular progesterone administration for the prevention of preterm birth, a randomized clinical trial | IRCT201604119568N16 |
| Different Types of Progesterone in the Prevention of Preterm Labor | Intramuscular 17Alpha-hydroxyprogestrone, Progesterone Suppositories and Dydrogesterone Tablets in Preventing Preterm Labor | NCT03537287 |
| Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth | Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth | NCT02913495 |
| Vasomotor symptoms (VMS) and endothelial function: A randomised placebo-controlled trial of oral micronised Progesterone (Prometrium ®) | | ISRCTN16052610 |
| Evaluation of the effect of progesterone on latency period of preterm premature rupture of membrane | Evaluation of the effect of progesterone on latency period of preterm premature rupture of membrane in 24-34 weeks of gestation | IRCT2014020216453N1 |
| Uterine Contractions and Mode of Progesterone in Frozen Embryo Transfer (FET) Cycles: Randomized Clinical Trial | Uterine Contractions and Mode of Progesterone in Frozen Embryo Transfer (FET) Cycles: Randomized Clinical Trial | NCT02078869 |
| Sexual Absorption of Vaginal Progesterone | Sexual Absorption of Vaginal Progesterone | NCT01959464 |
| The effect of melatonin supplementation with progesterone on the improvement and level of inflammatory factors in patients with endometrial hyperplasia | The effect of melatonin supplementation with progesterone on the improvement and level of inflammatory factors in patients with endometrial hyperplasia | IRCT20220116053735N1 |
| Studying the effect of nimodipin, progesterone and magnesium sulfate in the treatment of severe head injury | Comparison study the effect of nimodipine, magnesium sulfate and progesterone in the treatment of severe head injury with conventional therapy on reducing mortality rate | IRCT201210229534N2 |
| The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients | The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Randomized Controlled Pilot Study in Normo-responder IVF Patients | NCT01980680 |
| Vitamin D and Progesterone for Acute Spinal Cord Injury | Effects of Synchronic Administration of Vitamin D and Progesterone on Outcome of Patients with Acute Spinal Cord Injury; A Randomized, Double Blind, Placebo Controlled Study | IRCT201310082445N2 |
| Endometrial preparation for cryo embryo transfer: effect of Gonadotropin Releasing Hormone Agonists (GnRHa) coupled with oestrogen and progesterone on hormonal profile and pregnancy rate | The effect of endometrial preparation by pretreatment with Gonadotrophin-releasing hormone agonist (GnRha), oestrogen and progesterone, compared to endometrial preparation by oestrogen and progesterone only, on clinical pregnancy rate in infertile couples undergoing cryo embryo transfer as treatment for infertility | ACTRN12613001316796 |
| Progesterone supplementation in natural cycles improves live birth rates after embryo transfer of frozen-thawed embryos—a randomized controlled trial | Studier om hur resultaten påverkas av progesteronsubstitution i lutealfas vid frysåterföring i naturlig cykel, efter tidigare genomgången IVF-behandling | NL-OMON28205 |
| Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. | Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. | NCT02032797 |
| A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women | An Open-Label, Single-Dose, Randomized, 2-Treatment, 2-Period Crossover Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings 20% (w/w) in Postmenopausal Women | NCT02092571 |
| Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTM | Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Sonographic Short Cervix and History of Preterm Labor and/or Midtrimester Miscarriage | NCT02673359 |
| Comparison live birth rate in hormone replacement frozen embryo transfer cycles with vaginal gel and intramuscular progesterone: A prospective randomized trial in Chinese population | DNA methylation studies during the implantation window in human endometrium | ChiCTR-TRC-14004565 |
| Effect Evaluation of Melatonin in treatment of Polycystic Ovarian Syndrome | Comparing the Effect of Melatonin with Placebo in Combination with Medroxy Progesterone in Women with Polycystic Ovarian Syndrome | IRCT20200711048078N1 |
| The effectiveness of reducing the incidence of preterm birth in IVF/ICSI twins using natural progesterone starting from the first trimester | Double-blind, placebo-controlled, single-center randomized trial to study the effectiveness of reducing the incidence of preterm birth in IVF/ICSI twins using natural progesterone starting from the first trimester | ISRCTN69810120 |
